[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_b2e54b30-7ce0-48c0-afeb-58c50207dac9":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:b2e54b30-7ce0-48c0-afeb-58c50207dac9,\"}":813},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":661,"relativeEntities":662,"slug":663,"properties":664,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":675,"manageAffiliations":708,"indexDatabases":760,"url":803,"thumbnailPath":26,"statistic":804,"gsStatistic":26,"type":26,"analyzePriority":26},"b2e54b30-7ce0-48c0-afeb-58c50207dac9","2023-05-29T11:31:02.726+00:00","2025-11-21T10:01:47.401+00:00",[],"Anti-Cancer-Drugs",{"country":665,"issn":667,"introduce":669,"eissn":671,"title":673},{"VOID":666},"US",{"VOID":668},"09594973",{"EN":670},"Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.",{"VOID":672},"14735741",{"EN":674},"Anti-Cancer Drugs",[676,684,692,700],{"id":677,"createTime":678,"updateTime":679,"relativeEntities":680,"label":681,"description":683,"parentId":26,"standard":26,"scholarHubFieldId":26},"d9687dc3-fd83-46ff-aef4-1925044c24eb","2023-05-29T10:24:05.052+00:00","2023-11-21T05:08:37.643+00:00",[],{"EN":682},"Oncology",{},{"id":685,"createTime":686,"updateTime":687,"relativeEntities":688,"label":689,"description":691,"parentId":26,"standard":26,"scholarHubFieldId":26},"8d3ee16d-8f93-4e34-b94e-cd3a00dde338","2023-05-29T10:24:36.755+00:00","2023-11-21T05:10:53.773+00:00",[],{"EN":690},"Pharmacology (medical)",{},{"id":693,"createTime":694,"updateTime":695,"relativeEntities":696,"label":697,"description":699,"parentId":26,"standard":26,"scholarHubFieldId":26},"740fbbd4-0204-4499-bc5d-be3ba61fc9be","2023-05-29T10:24:05.032+00:00","2023-11-21T05:08:37.653+00:00",[],{"EN":698},"Cancer Research",{},{"id":701,"createTime":702,"updateTime":703,"relativeEntities":704,"label":705,"description":707,"parentId":26,"standard":26,"scholarHubFieldId":26},"8b51d244-613f-4ff9-b308-d32de7c33ed9","2023-05-29T10:24:08.511+00:00","2023-11-21T07:37:03.796+00:00",[],{"EN":706},"Pharmacology",{},[709,750],{"id":710,"createTime":711,"updateTime":712,"relativeEntities":713,"slug":714,"properties":715,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":158,"url":26,"parentIds":718,"statistic":719},"09833cb8-5a51-4978-b89f-63f09610a98d","2023-05-29T12:06:07.808+00:00","2025-06-11T22:27:16.929+00:00",[],"LIPPINCOTT-WILLIAMS-WILKINS",{"title":716},{"EN":717},"LIPPINCOTT WILLIAMS & WILKINS",[],{"impactFactor":36,"impactFactorByYear":720,"i10Index":397,"i10IndexLast5Year":36,"totalPublication":397,"totalPublicationByYear":722,"totalCitation":723,"totalCitationByYear":724,"totalCitationPerPublication":741,"totalCitationPerPublicationByYear":742,"hindexLast5Year":285,"hindex":285},{"2012":721,"2013":517},42.33,{"1978":115,"1980":59,"1985":115,"1986":115,"1999":115,"2000":115,"2001":115,"2002":114,"2004":59,"2005":111,"2006":115,"2007":162,"2008":59,"2009":162,"2010":114,"2011":115},53806,{"1978":725,"1980":726,"1985":727,"1986":728,"1999":729,"2000":730,"2001":731,"2002":732,"2004":733,"2005":734,"2006":735,"2007":736,"2008":737,"2009":738,"2010":739,"2011":740},61,237,2578,4097,3480,451,3720,1291,3152,12264,1357,2715,1509,14579,1587,728,1537.31,{"1978":725,"1980":652,"1985":727,"1986":728,"1999":729,"2000":730,"2001":731,"2002":743,"2004":744,"2005":745,"2006":735,"2007":746,"2008":747,"2009":748,"2010":749,"2011":740},645.5,1050.67,3066,543,503,2915.8,793.5,{"id":751,"createTime":752,"updateTime":753,"relativeEntities":754,"slug":755,"properties":756,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":162,"url":26,"parentIds":759,"statistic":26},"34432dfd-8a81-4cb8-a3f5-0ee8b74bbd54","2023-05-29T10:24:05.014+00:00","2025-11-21T10:07:46.877+00:00",[],"Lippincott-Williams-and-Wilkins-Ltd-",{"title":757},{"EN":758},"Lippincott Williams and Wilkins Ltd.",[],[761,783],{"id":762,"indexDatabase":763,"url":775,"indexYears":776,"academicFieldIds":777,"indexDatabaseRanking":782},"b884d7e1-bcf4-4d31-857f-5cf8a2867eea",{"id":764,"createTime":765,"updateTime":766,"relativeEntities":767,"label":768,"description":770,"key":772,"publicationTags":773,"standard":26},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":769,"VI":769},"Scopus - Elsevier",{"EN":769,"VI":771},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[774],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F28727","1990-2025",[778,779,780,781],"46eddd1f-e049-4237-8609-9d60083086ad","ee505398-b96f-423d-82ed-9f73f07d49d4","462e3fe4-4fc0-4c02-80d6-8d2af4fc74ea","e39d1b91-b03d-48ed-87bb-ab5b714ad558","SCOPUS__Q1",{"id":784,"indexDatabase":785,"url":799,"indexYears":26,"academicFieldIds":800,"indexDatabaseRanking":26},"3eff7d21-c513-4602-a8a5-32ae384b4848",{"id":786,"createTime":787,"updateTime":788,"relativeEntities":789,"label":790,"description":792,"key":795,"publicationTags":796,"standard":26},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":791,"VI":791},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":793,"EN":794},"Cơ sở dữ liệu SCIE","SCIE database","scie",[797,798],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0959-4973",[801,802],"2b943d65-24a8-4546-9232-a1e32c12cb6c","248e54de-c562-4c06-8a10-d7f8a37c06fe","https:\u002F\u002Fjournals.lww.com\u002Fanti-cancerdrugs\u002Fpages\u002Faboutthejournal.aspx",{"impactFactor":36,"impactFactorByYear":805,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":806,"totalCitation":807,"totalCitationByYear":808,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":812,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},302,{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},55,91,50.33,{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"meta":814,"data":816},{"total":815},"28",[817,1545,2228,2560,2770,3108,3352,3437,3631,3803],{"id":818,"createTime":819,"updateTime":819,"relativeEntities":820,"slug":821,"properties":822,"entityType":835,"verifyStatus":25,"verifyTime":836,"verifyNote":837,"syncStatus":28,"languages":838,"translateLanguages":26,"viewCount":36,"primaryUrl":839,"fullTextUrl":26,"authors":840,"publicationType":922,"publisherRelationship":923,"citationCount":961,"citationInfo":962,"publishDate":964,"publishYear":965,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":966,"isForceReanalyzing":1544},"65fa8d81-ad7e-4470-b332-cc44297a7491","2024-10-13T05:01:51.942+00:00",[],"A-systematic-review-of-the-anticancer-properties-of-berberine-a-natural-product-from-Chinese-herbs",{"mag":823,"keywords":825,"openalex":826,"abstract":828,"title":829,"pm":831,"doi":833},{"VOID":824},"2171918265",{},{"VOID":827},"W2171918265",{},{"EN":830},"A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs",{"VOID":832},"19704371",{"VOID":834},"10.1097\u002Fcad.0b013e328330d95b","PUBLICATION","2024-10-13T05:01:51.941+00:00","Auto Verify",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-200910000-00001",[841,860,881,903],{"id":842,"sortIndex":115,"researcher":26,"roles":843,"affiliations":844,"properties":855},"a0cc7fd2-44eb-4728-bafa-4670c92a4c2e",[],[845],{"id":846,"sortIndex":36,"affiliation":847,"properties":26},"7e9d6625-734f-4b19-990f-21c5eeaedb33",{"id":848,"createTime":849,"updateTime":849,"relativeEntities":850,"slug":851,"properties":852,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"818bc6cd-9a1c-4933-b40e-af140cedeff7","2024-10-13T05:01:51.969+00:00",[],"Department-of-Dermatology-People-s-Hospital-of-Binzhou-Binzhou",{"title":853},{"EN":854},"Department of Dermatology, People's Hospital of Binzhou, Binzhou",{"openalex":856,"title":858},{"VOID":857},"A5081804702",{"EN":859},"Keli Xun",{"id":861,"sortIndex":59,"researcher":26,"roles":862,"affiliations":863,"properties":874},"7e101279-b634-412a-bdb9-974ec4e07ad3",[],[864],{"id":865,"sortIndex":36,"affiliation":866,"properties":26},"48e23106-ba36-4975-b2b6-c8f625c78ef6",{"id":867,"createTime":868,"updateTime":868,"relativeEntities":869,"slug":870,"properties":871,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"10a7ddbe-db31-420b-927f-5357f5691713","2024-10-13T05:01:51.987+00:00",[],"to-Dr-Xiuping-Chen-Avenida-Padre-Tomas-Pereira-SJ-Taipa-Macau-China",{"title":872},{"EN":873},"to Dr Xiuping Chen, Avenida Padre Tomas Pereira SJ, Taipa, Macau, China",{"openalex":875,"orcid":877,"title":879},{"VOID":876},"A5061972415",{"VOID":878},"https:\u002F\u002Forcid.org\u002F0000-0003-2675-7645",{"EN":880},"Xiuping Chen",{"id":882,"sortIndex":114,"researcher":26,"roles":883,"affiliations":884,"properties":896},"c3aa9cb2-a7fa-493c-9839-dd51250742fd",[],[885],{"id":886,"sortIndex":36,"affiliation":887,"properties":26},"9781ae1f-40d4-4493-8c9e-2bdc7aca95b9",{"id":888,"createTime":889,"updateTime":890,"relativeEntities":891,"slug":892,"properties":893,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b4260cd6-d36b-4cb1-aa7b-8f035927aaa1","2024-01-04T10:16:43.168+00:00","2024-10-13T05:01:51.978+00:00",[],"Institute-of-Chinese-Medical-Sciences-University-of-Macau-Macau-China",{"title":894},{"VI":895},"Institute of Chinese Medical Sciences, University of Macau, Macau, China",{"openalex":897,"orcid":899,"title":901},{"VOID":898},"A5074757942",{"VOID":900},"https:\u002F\u002Forcid.org\u002F0000-0003-4355-6490",{"EN":902},"Yitao Wang",{"id":904,"sortIndex":36,"researcher":26,"roles":905,"affiliations":906,"properties":917},"6a3ac60e-8e4a-4ac1-b152-0bf6ef8fc519",[],[907],{"id":908,"sortIndex":36,"affiliation":909,"properties":26},"09a8b6fd-f7d6-42c0-85b0-375a7041dc7e",{"id":910,"createTime":911,"updateTime":911,"relativeEntities":912,"slug":913,"properties":914,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c6023f0f-37a1-4692-8f40-03161da6e493","2024-10-13T05:01:51.956+00:00",[],"School-of-Pharmacy-Chengdu-Medical-College-Chengdu",{"title":915},{"EN":916},"School of Pharmacy, Chengdu Medical College, Chengdu",{"openalex":918,"title":920},{"VOID":919},"A5034158066",{"EN":921},"Yiyi Sun","ARTICLE",{"url":26,"publisher":924,"properties":954},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":925,"slug":663,"properties":926,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":932,"manageAffiliations":933,"indexDatabases":934,"url":803,"thumbnailPath":26,"statistic":949,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":927,"issn":928,"introduce":929,"eissn":930,"title":931},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[935,942],{"id":762,"indexDatabase":936,"url":775,"indexYears":776,"academicFieldIds":941,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":937,"label":938,"description":939,"key":772,"publicationTags":940,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":943,"url":799,"indexYears":26,"academicFieldIds":948,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":944,"label":945,"description":946,"key":795,"publicationTags":947,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":950,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":951,"totalCitation":807,"totalCitationByYear":952,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":953,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":955,"pages":957,"issue":959},{"VOID":956},"20",{"VOID":958},"757-769",{"VOID":960},"9",393,{"total":961,"publishYear":26,"statisticByYear":963},{"2012":239,"2013":222,"2014":285,"2015":396,"2016":255,"2017":257,"2018":260,"2019":240,"2020":398,"2021":397,"2022":260,"2023":242,"2024":116},"2009-10-01",2009,[967,971,975,978,982,986,990,993,997,1001,1005,1009,1013,1017,1020,1024,1027,1031,1035,1039,1043,1047,1051,1055,1059,1063,1067,1071,1075,1079,1083,1087,1091,1095,1099,1103,1106,1110,1114,1118,1122,1126,1130,1134,1138,1142,1146,1150,1153,1157,1161,1165,1168,1172,1176,1180,1184,1187,1191,1195,1199,1203,1207,1211,1215,1219,1223,1227,1231,1235,1239,1243,1247,1250,1254,1258,1262,1266,1270,1273,1276,1279,1283,1287,1291,1295,1299,1303,1307,1311,1315,1319,1323,1327,1331,1335,1339,1343,1347,1350,1353,1357,1361,1365,1369,1373,1377,1380,1384,1388,1391,1394,1397,1401,1405,1409,1413,1417,1421,1425,1429,1433,1437,1441,1445,1449,1452,1456,1460,1464,1468,1472,1476,1480,1484,1488,1492,1496,1499,1502,1506,1510,1513,1517,1521,1525,1529,1533,1537,1541],{"id":26,"text":968,"url":26,"identifiers":969},"Da Rocha, 2001, Natural products in anticancer therapy, Curr Opin Pharmacol, 1, 364, 10.1016\u002FS1471-4892(01)00063-7",{"doi":970},"10.1016\u002FS1471-4892(01)00063-7",{"id":26,"text":972,"url":26,"identifiers":973},"Imanshahidi, 2008, Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine, Phytother Res, 22, 999, 10.1002\u002Fptr.2399",{"doi":974},"10.1002\u002Fptr.2399",{"id":26,"text":976,"url":26,"identifiers":977},"Singhal, 1976, Anthelmintic activity of berberine hydrochloride against Syphacia obvelata in mice, Indian J Exp Biol, 14, 345",{},{"id":26,"text":979,"url":26,"identifiers":980},"Satou, 2002, Inhibitory effect of isoquinoline alkaloids on movement of second-stage larvae of Toxocara canis, Biol Pharm Bull, 25, 1651, 10.1248\u002Fbpb.25.1651",{"doi":981},"10.1248\u002Fbpb.25.1651",{"id":26,"text":983,"url":26,"identifiers":984},"Kuo, 2004, The anti-inflammatory potential of berberine in vitro and in vivo, Cancer Lett, 203, 127, 10.1016\u002Fj.canlet.2003.09.002",{"doi":985},"10.1016\u002Fj.canlet.2003.09.002",{"id":26,"text":987,"url":26,"identifiers":988},"Franzblau, 1986, Comparative in vitro antimicrobial activity of Chinese medicinal herbs, J Ethnopharmacol, 15, 279, 10.1016\u002F0378-8741(86)90166-2",{"doi":989},"10.1016\u002F0378-8741(86)90166-2",{"id":26,"text":991,"url":26,"identifiers":992},"Zhang, 1997, A study of Helicobacterium pylori and prevention and treatment of chronic atrophic gastritis, J Tradit Chin Med, 17, 3",{},{"id":26,"text":994,"url":26,"identifiers":995},"Yang, 1996, In vitro response of Blastocystis hominis against traditional Chinese medicine, J Ethnopharmacol, 55, 35, 10.1016\u002FS0378-8741(96)01471-7",{"doi":996},"10.1016\u002FS0378-8741(96)01471-7",{"id":26,"text":998,"url":26,"identifiers":999},"Mahady, 2003, In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis, Phytother Res, 17, 217, 10.1002\u002Fptr.1108",{"doi":1000},"10.1002\u002Fptr.1108",{"id":26,"text":1002,"url":26,"identifiers":1003},"Romero, 2005, Effect of artemisinin\u002Fartesunate as inhibitors of hepatitis B virus production in an ‘in vitro’ replicative system, Antiviral Res, 68, 75, 10.1016\u002Fj.antiviral.2005.07.005",{"doi":1004},"10.1016\u002Fj.antiviral.2005.07.005",{"id":26,"text":1006,"url":26,"identifiers":1007},"Li, 2008, Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity, Chem Biodivers, 5, 777, 10.1002\u002Fcbdv.200890074",{"doi":1008},"10.1002\u002Fcbdv.200890074",{"id":26,"text":1010,"url":26,"identifiers":1011},"Ferreira, 2008, Helicobacter and gastric malignancies, Helicobacter, 13, 28, 10.1111\u002Fj.1523-5378.2008.00633.x",{"doi":1012},"10.1111\u002Fj.1523-5378.2008.00633.x",{"id":26,"text":1014,"url":26,"identifiers":1015},"Farinati, 2008, Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway, Eur J Cancer Prev, 17, 195, 10.1097\u002FCEJ.0b013e3282f0bff5",{"doi":1016},"10.1097\u002FCEJ.0b013e3282f0bff5",{"id":26,"text":1018,"url":26,"identifiers":1019},"Wang, 1987, Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas, Cancer Res, 47, 4192",{},{"id":26,"text":1021,"url":26,"identifiers":1022},"Chang, 1990, Berberine-induced morphologic differentiation and down- regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells, Cancer Lett, 55, 103, 10.1016\u002F0304-3835(90)90018-S",{"doi":1023},"10.1016\u002F0304-3835(90)90018-S",{"id":26,"text":1025,"url":26,"identifiers":1026},"Chang, 1991, Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma cells treated with berberine, J Formos Med Assoc, 90, 10",{},{"id":26,"text":1028,"url":26,"identifiers":1029},"Liang, 2008, Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells, Eur J Pharmacol, 590, 343, 10.1016\u002Fj.ejphar.2008.06.034",{"doi":1030},"10.1016\u002Fj.ejphar.2008.06.034",{"id":26,"text":1032,"url":26,"identifiers":1033},"Katiyar, 2009, p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo, Mol Carcinog, 47, 24, 10.1002\u002Fmc.20453",{"doi":1034},"10.1002\u002Fmc.20453",{"id":26,"text":1036,"url":26,"identifiers":1037},"Shen, 2005, Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents, Antioxid Redox Signal, 7, 1648, 10.1089\u002Fars.2005.7.1648",{"doi":1038},"10.1089\u002Fars.2005.7.1648",{"id":26,"text":1040,"url":26,"identifiers":1041},"Fukuda, 1999, Inhibition of activator protein 1 activity by berberine in human hepatoma cells, Planta Med, 65, 381, 10.1055\u002Fs-2006-960795",{"doi":1042},"10.1055\u002Fs-2006-960795",{"id":26,"text":1044,"url":26,"identifiers":1045},"Pandey, 2008, Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis, Cancer Res, 68, 5370, 10.1158\u002F0008-5472.CAN-08-0511",{"doi":1046},"10.1158\u002F0008-5472.CAN-08-0511",{"id":26,"text":1048,"url":26,"identifiers":1049},"Mantena, 2006, Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP, Carcinogenesis, 27, 2018, 10.1093\u002Fcarcin\u002Fbgl043",{"doi":1050},"10.1093\u002Fcarcin\u002Fbgl043",{"id":26,"text":1052,"url":26,"identifiers":1053},"Letasiova, 2006, Berberine-antiproliferative activity in vitro and induction of apoptosis\u002Fnecrosis of the U937 and B16 cells, Cancer Lett, 239, 254, 10.1016\u002Fj.canlet.2005.08.024",{"doi":1054},"10.1016\u002Fj.canlet.2005.08.024",{"id":26,"text":1056,"url":26,"identifiers":1057},"Wu, 1999, Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin\u002FB23 and telomerase activity, Int J Cancer, 81, 923, 10.1002\u002F(SICI)1097-0215(19990611)81:6\u003C923::AID-IJC14>3.0.CO;2-D",{"doi":1058},"10.1002\u002F(SICI)1097-0215(19990611)81:6\u003C923::AID-IJC14>3.0.CO;2-D",{"id":26,"text":1060,"url":26,"identifiers":1061},"Krey, 1969, Berberine: complex with DNA, Science, 166, 755, 10.1126\u002Fscience.166.3906.755",{"doi":1062},"10.1126\u002Fscience.166.3906.755",{"id":26,"text":1064,"url":26,"identifiers":1065},"Rungsitiyakorn, 1981, On the pH dependence of binding of berberine to DNA, J Pharm Pharmacol, 33, 125, 10.1111\u002Fj.2042-7158.1981.tb13732.x",{"doi":1066},"10.1111\u002Fj.2042-7158.1981.tb13732.x",{"id":26,"text":1068,"url":26,"identifiers":1069},"Creasey, 1979, Biochemical effects of berberine, Biochem Pharmacol, 28, 1081, 10.1016\u002F0006-2952(79)90308-3",{"doi":1070},"10.1016\u002F0006-2952(79)90308-3",{"id":26,"text":1072,"url":26,"identifiers":1073},"Islam, 2008, RNA targeting by small molecule alkaloids: studies on the binding of berberine and palmatine to polyribonucleotides and comparison to ethidium, J Mol Struct, 875, 382, 10.1016\u002Fj.molstruc.2007.05.004",{"doi":1074},"10.1016\u002Fj.molstruc.2007.05.004",{"id":26,"text":1076,"url":26,"identifiers":1077},"Serafim, 2008, Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line, Cancer Chemother Pharmacol, 61, 1007, 10.1007\u002Fs00280-007-0558-9",{"doi":1078},"10.1007\u002Fs00280-007-0558-9",{"id":26,"text":1080,"url":26,"identifiers":1081},"Xia, 2007, Study of the interactions of berberine and daunorubicin with DNA using alternating penalty trilinear decomposition algorithm combined with excitation-emission matrix fluorescence data, Talanta, 73, 606, 10.1016\u002Fj.talanta.2007.04.020",{"doi":1082},"10.1016\u002Fj.talanta.2007.04.020",{"id":26,"text":1084,"url":26,"identifiers":1085},"Bhadra, 2008, Berberine-DNA complexation: new insights into the cooperative binding and energetic aspects, Biochim Biophys Acta Gen Subj, 1780, 1054, 10.1016\u002Fj.bbagen.2008.05.005",{"doi":1086},"10.1016\u002Fj.bbagen.2008.05.005",{"id":26,"text":1088,"url":26,"identifiers":1089},"Islam, 2008, Binding of DNA-binding alkaloids berberine and palmatine to tRNA and comparison to ethidium: spectroscopic and molecular modeling studies, J Mol Struct, 891, 498, 10.1016\u002Fj.molstruc.2008.04.043",{"doi":1090},"10.1016\u002Fj.molstruc.2008.04.043",{"id":26,"text":1092,"url":26,"identifiers":1093},"Islam, 2007, RNA binding small molecules: studies on t-RNA binding by cytotoxic plant alkaloids berberine, palmatine and the comparison to ethidium, Biophys Chem, 125, 508, 10.1016\u002Fj.bpc.2006.11.001",{"doi":1094},"10.1016\u002Fj.bpc.2006.11.001",{"id":26,"text":1096,"url":26,"identifiers":1097},"Tian, 2008, Interaction of anticancer herbal drug berberine with DNA immobilized on the glassy carbon electrode, Bioelectrochemistry, 73, 18, 10.1016\u002Fj.bioelechem.2008.02.005",{"doi":1098},"10.1016\u002Fj.bioelechem.2008.02.005",{"id":26,"text":1100,"url":26,"identifiers":1101},"Liu, 2009, Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage, Mutat Res, 662, 75, 10.1016\u002Fj.mrfmmm.2008.12.009",{"doi":1102},"10.1016\u002Fj.mrfmmm.2008.12.009",{"id":26,"text":1104,"url":26,"identifiers":1105},"Weber, 1985, N-acetylation pharmacogenetics, Pharmacol Rev, 37, 25",{},{"id":26,"text":1107,"url":26,"identifiers":1108},"Butcher, 2008, Regulation of arylamine N-acetyltransferases, Curr Drug Metab, 9, 498, 10.2174\u002F138920008784892128",{"doi":1109},"10.2174\u002F138920008784892128",{"id":26,"text":1111,"url":26,"identifiers":1112},"Sim, 2003, Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function, Biochem Soc Trans, 31, 615, 10.1042\u002Fbst0310615",{"doi":1113},"10.1042\u002Fbst0310615",{"id":26,"text":1115,"url":26,"identifiers":1116},"Chung, 1999, Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells, Food Chem Toxicol, 37, 319, 10.1016\u002FS0278-6915(99)00016-2",{"doi":1117},"10.1016\u002FS0278-6915(99)00016-2",{"id":26,"text":1119,"url":26,"identifiers":1120},"Lin, 1999, Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells, Am J Chin Med, 27, 265, 10.1142\u002FS0192415X99000306",{"doi":1121},"10.1142\u002FS0192415X99000306",{"id":26,"text":1123,"url":26,"identifiers":1124},"Chung, 2000, Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells, Am J Chin Med, 28, 227, 10.1142\u002FS0192415X00000271",{"doi":1125},"10.1142\u002FS0192415X00000271",{"id":26,"text":1127,"url":26,"identifiers":1128},"Wang, 2002, Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T\u002FVGH) and brain glioblastoma multiforms (GBM 8401) cells, Neurochem Res, 27, 883, 10.1023\u002FA:1020335430016",{"doi":1129},"10.1023\u002FA:1020335430016",{"id":26,"text":1131,"url":26,"identifiers":1132},"Misra, 2008, Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer, Connect Tissue Res, 49, 219, 10.1080\u002F03008200802143356",{"doi":1133},"10.1080\u002F03008200802143356",{"id":26,"text":1135,"url":26,"identifiers":1136},"Lin, 2005, Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells, Phytomedicine, 12, 351, 10.1016\u002Fj.phymed.2003.11.008",{"doi":1137},"10.1016\u002Fj.phymed.2003.11.008",{"id":26,"text":1139,"url":26,"identifiers":1140},"Rundhaug, 2008, Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis, Photochem Photobiol, 84, 322, 10.1111\u002Fj.1751-1097.2007.00261.x",{"doi":1141},"10.1111\u002Fj.1751-1097.2007.00261.x",{"id":26,"text":1143,"url":26,"identifiers":1144},"Aparicio Gallego, 2007, Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer, Clin Transl Oncol, 9, 694, 10.1007\u002Fs12094-007-0126-0",{"doi":1145},"10.1007\u002Fs12094-007-0126-0",{"id":26,"text":1147,"url":26,"identifiers":1148},"Breinig, 2007, Cyclooxygenase-2 (COX-2) – a therapeutic target in liver cancer?, Curr Pharm Des, 13, 3305, 10.2174\u002F138161207782360627",{"doi":1149},"10.2174\u002F138161207782360627",{"id":26,"text":1151,"url":26,"identifiers":1152},"Patel, 2007, Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer, Indian J Biochem Biophys, 44, 419",{},{"id":26,"text":1154,"url":26,"identifiers":1155},"Sarkar, 2007, Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy, Mini Rev Med Chem, 7, 599, 10.2174\u002F138955707780859431",{"doi":1156},"10.2174\u002F138955707780859431",{"id":26,"text":1158,"url":26,"identifiers":1159},"Singh-Ranger, 2008, The role of cyclooxygenase-2 in breast cancer: review, Breast Cancer Res Treat, 109, 189, 10.1007\u002Fs10549-007-9641-5",{"doi":1160},"10.1007\u002Fs10549-007-9641-5",{"id":26,"text":1162,"url":26,"identifiers":1163},"Fukuda, 1999, Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells, J Ethnopharmacol, 66, 227, 10.1016\u002FS0378-8741(98)00162-7",{"doi":1164},"10.1016\u002FS0378-8741(98)00162-7",{"id":26,"text":1166,"url":26,"identifiers":1167},"Kuo, 2005, Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells, In Vivo, 19, 247",{},{"id":26,"text":1169,"url":26,"identifiers":1170},"Liu, 2009, Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells, Biochem Biophys Res Commun, 378, 174, 10.1016\u002Fj.bbrc.2008.10.169",{"doi":1171},"10.1016\u002Fj.bbrc.2008.10.169",{"id":26,"text":1173,"url":26,"identifiers":1174},"Seaver, 2004, Inhibition of COX isoforms by nutraceuticals, J Herb Pharmacother, 4, 11, 10.1080\u002FJ157v04n02_02",{"doi":1175},"10.1080\u002FJ157v04n02_02",{"id":26,"text":1177,"url":26,"identifiers":1178},"Shay, 2008, Targeting telomerase for cancer therapeutics, Br J Cancer, 98, 677, 10.1038\u002Fsj.bjc.6604209",{"doi":1179},"10.1038\u002Fsj.bjc.6604209",{"id":26,"text":1181,"url":26,"identifiers":1182},"Harley, 2008, Telomerase and cancer therapeutics, Nat Rev Cancer, 8, 167, 10.1038\u002Fnrc2275",{"doi":1183},"10.1038\u002Fnrc2275",{"id":26,"text":1185,"url":26,"identifiers":1186},"Biao, 2007, Study the ef fect of berber ine on the telomerase activity of human nasopharyngeal carcinoma (NPC) CNE-2, Shanxi Med J, 36, 1281",{},{"id":26,"text":1188,"url":26,"identifiers":1189},"Sriwilaijareon, 2002, Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine, Parasitol Int, 51, 99, 10.1016\u002FS1383-5769(01)00092-7",{"doi":1190},"10.1016\u002FS1383-5769(01)00092-7",{"id":26,"text":1192,"url":26,"identifiers":1193},"Makhey, 1996, Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons, Bioorg Med Chem, 4, 781, 10.1016\u002F0968-0896(96)00054-5",{"doi":1194},"10.1016\u002F0968-0896(96)00054-5",{"id":26,"text":1196,"url":26,"identifiers":1197},"Kim, 1998, Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine, Biochemistry, 37, 16316, 10.1021\u002Fbi9810961",{"doi":1198},"10.1021\u002Fbi9810961",{"id":26,"text":1200,"url":26,"identifiers":1201},"Mantena, 2006, Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells, Mol Cancer Ther, 5, 296, 10.1158\u002F1535-7163.MCT-05-0448",{"doi":1202},"10.1158\u002F1535-7163.MCT-05-0448",{"id":26,"text":1204,"url":26,"identifiers":1205},"Kettmann, 2004, Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model, J Comput Aided Mol Des, 18, 785, 10.1007\u002Fs10822-004-7878-1",{"doi":1206},"10.1007\u002Fs10822-004-7878-1",{"id":26,"text":1208,"url":26,"identifiers":1209},"Kobayashi, 1995, Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes, Planta Med, 61, 414, 10.1055\u002Fs-2006-958127",{"doi":1210},"10.1055\u002Fs-2006-958127",{"id":26,"text":1212,"url":26,"identifiers":1213},"Wang, 1996, Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne, Chem Res Toxicol, 9, 75, 10.1021\u002Ftx950080y",{"doi":1214},"10.1021\u002Ftx950080y",{"id":26,"text":1216,"url":26,"identifiers":1217},"Li, 2000, Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug- enzyme interactions, Biochemistry, 39, 7107, 10.1021\u002Fbi000171g",{"doi":1218},"10.1021\u002Fbi000171g",{"id":26,"text":1220,"url":26,"identifiers":1221},"Kang, 2002, Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine, Mol Pharmacol, 61, 879, 10.1124\u002Fmol.61.4.879",{"doi":1222},"10.1124\u002Fmol.61.4.879",{"id":26,"text":1224,"url":26,"identifiers":1225},"Qin, 2007, Inhibition of DNA topoisomerase I by natural and synthetic mono- and dimeric protoberberine alkaloids, Chem Biodivers, 4, 481, 10.1002\u002Fcbdv.200790040",{"doi":1226},"10.1002\u002Fcbdv.200790040",{"id":26,"text":1228,"url":26,"identifiers":1229},"Jantova, 2003, Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells, J Pharm Pharmacol, 55, 1143, 10.1211\u002F002235703322277186",{"doi":1230},"10.1211\u002F002235703322277186",{"id":26,"text":1232,"url":26,"identifiers":1233},"Jantova, 2007, Berberine induces apoptosis through a mitochondrial\u002F caspase pathway in human promonocytic U937 cells, Toxicol In Vitro, 21, 25, 10.1016\u002Fj.tiv.2006.07.015",{"doi":1234},"10.1016\u002Fj.tiv.2006.07.015",{"id":26,"text":1236,"url":26,"identifiers":1237},"Lin, 2006, Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line, World J Gastroenterol, 12, 21, 10.3748\u002Fwjg.v12.i1.21",{"doi":1238},"10.3748\u002Fwjg.v12.i1.21",{"id":26,"text":1240,"url":26,"identifiers":1241},"Wang, 2008, Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine, Phytomedicine, 15, 1062, 10.1016\u002Fj.phymed.2008.05.002",{"doi":1242},"10.1016\u002Fj.phymed.2008.05.002",{"id":26,"text":1244,"url":26,"identifiers":1245},"Kim, 2008, Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells, Planta Med, 74, 1693, 10.1055\u002Fs-0028-1088313",{"doi":1246},"10.1055\u002Fs-0028-1088313",{"id":26,"text":1248,"url":26,"identifiers":1249},"Lin, 2004, Berberine inhibits HIF-1alpha expression via enhanced proteolysis, Mol Pharmacol, 66, 612",{},{"id":26,"text":1251,"url":26,"identifiers":1252},"Lin, 2008, Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide, BMC Cancer, 8, 58, 10.1186\u002F1471-2407-8-58",{"doi":1253},"10.1186\u002F1471-2407-8-58",{"id":26,"text":1255,"url":26,"identifiers":1256},"Lee, 2006, Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model, Atherosclerosis, 186, 29, 10.1016\u002Fj.atherosclerosis.2005.06.048",{"doi":1257},"10.1016\u002Fj.atherosclerosis.2005.06.048",{"id":26,"text":1259,"url":26,"identifiers":1260},"Kim, 2008, Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes, Phytomedicine, 15, 340, 10.1016\u002Fj.phymed.2007.09.011",{"doi":1261},"10.1016\u002Fj.phymed.2007.09.011",{"id":26,"text":1263,"url":26,"identifiers":1264},"Letasiova, 2005, Antiproliferative activity of berberine in vitro and in vivo, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 149, 461, 10.5507\u002Fbp.2005.080",{"doi":1265},"10.5507\u002Fbp.2005.080",{"id":26,"text":1267,"url":26,"identifiers":1268},"Li, 2008, Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells, Biomed Pharmacother, 62, 573, 10.1016\u002Fj.biopha.2008.08.003",{"doi":1269},"10.1016\u002Fj.biopha.2008.08.003",{"id":26,"text":1271,"url":26,"identifiers":1272},"Yount, 2004, Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro, J Exp Ther Oncol, 4, 137",{},{"id":26,"text":1274,"url":26,"identifiers":1275},"Issat, 2006, Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic\u002Fcytotoxic effects independently from the mevalonate pathway, Oncol Rep, 16, 1273",{},{"id":26,"text":1277,"url":26,"identifiers":1278},"Szeto, 2002, Characterization of berberine on human cancer cells in culture, Turk J Med Sci, 32, 363",{},{"id":26,"text":1280,"url":26,"identifiers":1281},"Letasiova, 2006, Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells, J Pharm Pharmacol, 58, 263, 10.1211\u002Fjpp.58.2.0015",{"doi":1282},"10.1211\u002Fjpp.58.2.0015",{"id":26,"text":1284,"url":26,"identifiers":1285},"Chi, 1994, Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells, Life Sci, 54, 2099, 10.1016\u002F0024-3205(94)00719-5",{"doi":1286},"10.1016\u002F0024-3205(94)00719-5",{"id":26,"text":1288,"url":26,"identifiers":1289},"Hwang, 2002, Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver, Arch Toxicol, 76, 664, 10.1007\u002Fs00204-002-0351-9",{"doi":1290},"10.1007\u002Fs00204-002-0351-9",{"id":26,"text":1292,"url":26,"identifiers":1293},"Peng, 2006, Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2, Toxicol Appl Pharmacol, 214, 8, 10.1016\u002Fj.taap.2005.11.010",{"doi":1294},"10.1016\u002Fj.taap.2005.11.010",{"id":26,"text":1296,"url":26,"identifiers":1297},"Mitani, 2001, Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma, Cancer Lett, 165, 35, 10.1016\u002FS0304-3835(00)00710-2",{"doi":1298},"10.1016\u002FS0304-3835(00)00710-2",{"id":26,"text":1300,"url":26,"identifiers":1301},"Iizuka, 2000, Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines, Cancer Lett, 148, 19, 10.1016\u002FS0304-3835(99)00264-5",{"doi":1302},"10.1016\u002FS0304-3835(99)00264-5",{"id":26,"text":1304,"url":26,"identifiers":1305},"Wu, 1998, Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells, Life Sci, 62, 2283, 10.1016\u002FS0024-3205(98)00209-4",{"doi":1306},"10.1016\u002FS0024-3205(98)00209-4",{"id":26,"text":1308,"url":26,"identifiers":1309},"Tan, 2006, Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2, Mol Biosyst, 2, 250, 10.1039\u002Fb517116d",{"doi":1310},"10.1039\u002Fb517116d",{"id":26,"text":1312,"url":26,"identifiers":1313},"Pereira, 2007, Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions, J Pharmacol Exp Ther, 323, 636, 10.1124\u002Fjpet.107.128017",{"doi":1314},"10.1124\u002Fjpet.107.128017",{"id":26,"text":1316,"url":26,"identifiers":1317},"Jantova, 2006, Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells, J Photochem Photobiol B, 85, 163, 10.1016\u002Fj.jphotobiol.2006.07.001",{"doi":1318},"10.1016\u002Fj.jphotobiol.2006.07.001",{"id":26,"text":1320,"url":26,"identifiers":1321},"Orfila, 2000, Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro, J Ethnopharmacol, 71, 449, 10.1016\u002FS0378-8741(00)00177-X",{"doi":1322},"10.1016\u002FS0378-8741(00)00177-X",{"id":26,"text":1324,"url":26,"identifiers":1325},"Ko, 2000, Vasorelaxant and antiproliferative effects of berberine, Eur J Pharmacol, 399, 187, 10.1016\u002FS0014-2999(00)00339-3",{"doi":1326},"10.1016\u002FS0014-2999(00)00339-3",{"id":26,"text":1328,"url":26,"identifiers":1329},"Lin, 2004, Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth, Clin Exp Pharmacol Physiol, 31, 65, 10.1111\u002Fj.1440-1681.2004.03951.x",{"doi":1330},"10.1111\u002Fj.1440-1681.2004.03951.x",{"id":26,"text":1332,"url":26,"identifiers":1333},"Anis, 1999, Role of berberine as an adjuvant response modifier during tumour therapy in mice, Pharm Pharmacol Commun, 5, 697, 10.1211\u002F146080899128734415",{"doi":1334},"10.1211\u002F146080899128734415",{"id":26,"text":1336,"url":26,"identifiers":1337},"Yang, 1996, Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb\u002Fc 3T3 cells, Naunyn Schmiedebergs Arch Pharmacol, 354, 102, 10.1007\u002FBF00178709",{"doi":1338},"10.1007\u002FBF00178709",{"id":26,"text":1340,"url":26,"identifiers":1341},"Sethi, 1983, Enzyme inhibition VI: inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships, J Pharm Sci, 72, 538, 10.1002\u002Fjps.2600720515",{"doi":1342},"10.1002\u002Fjps.2600720515",{"id":26,"text":1344,"url":26,"identifiers":1345},"Weber, 2003, Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers, J Agric Food Chem, 51, 7352, 10.1021\u002Fjf034339r",{"doi":1346},"10.1021\u002Fjf034339r",{"id":26,"text":1348,"url":26,"identifiers":1349},"Lin, 2006, Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2\u002FM-phase of the cell cycle, Anticancer Res, 26, 1097",{},{"id":26,"text":1351,"url":26,"identifiers":1352},"Lin, 2007, Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway, Anticancer Res, 27, 3371",{},{"id":26,"text":1354,"url":26,"identifiers":1355},"Eom, 2008, Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial\u002Fcaspases pathway, Biol Pharm Bull, 31, 558, 10.1248\u002Fbpb.31.558",{"doi":1356},"10.1248\u002Fbpb.31.558",{"id":26,"text":1358,"url":26,"identifiers":1359},"Yokozawa, 2005, Protective role of Coptidis Rhizoma alkaloids against peroxynitrite-induced damage to renal tubular epithelial cells, J Pharm Pharmacol, 57, 367, 10.1211\u002F0022357055470",{"doi":1360},"10.1211\u002F0022357055470",{"id":26,"text":1362,"url":26,"identifiers":1363},"Li, 2000, Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells, Mol Pharmacol, 58, 1287, 10.1124\u002Fmol.58.6.1287",{"doi":1364},"10.1124\u002Fmol.58.6.1287",{"id":26,"text":1366,"url":26,"identifiers":1367},"Hsu, 2007, Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK\u002Fp38MAPK and FasL, Arch Toxicol, 81, 719, 10.1007\u002Fs00204-006-0169-y",{"doi":1368},"10.1007\u002Fs00204-006-0169-y",{"id":26,"text":1370,"url":26,"identifiers":1371},"Bremer, 2006, Targeted induction of apoptosis for cancer therapy: current progress and prospects, Trends Mol Med, 12, 382, 10.1016\u002Fj.molmed.2006.06.002",{"doi":1372},"10.1016\u002Fj.molmed.2006.06.002",{"id":26,"text":1374,"url":26,"identifiers":1375},"Kuo, 1995, Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells, Cancer Lett, 93, 193, 10.1016\u002F0304-3835(95)03809-B",{"doi":1376},"10.1016\u002F0304-3835(95)03809-B",{"id":26,"text":1378,"url":26,"identifiers":1379},"Lin, 2006, Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3, Anticancer Res, 26, 227",{},{"id":26,"text":1381,"url":26,"identifiers":1382},"Hwang, 2006, Berberine induces apoptosis through a mitochondria\u002Fcaspases pathway in human hepatoma cells, Arch Toxicol, 80, 62, 10.1007\u002Fs00204-005-0014-8",{"doi":1383},"10.1007\u002Fs00204-005-0014-8",{"id":26,"text":1385,"url":26,"identifiers":1386},"Piyanuch, 2007, Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells, Cancer Lett, 258, 230, 10.1016\u002Fj.canlet.2007.09.007",{"doi":1387},"10.1016\u002Fj.canlet.2007.09.007",{"id":26,"text":1389,"url":26,"identifiers":1390},"Choi, 2009, Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells, Int J Oncol, 34, 1221",{},{"id":26,"text":1392,"url":26,"identifiers":1393},"Choi, 2008, Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis, Anticancer Res, 28, 3777",{},{"id":26,"text":1395,"url":26,"identifiers":1396},"Lin, 2007, GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells, Anticancer Res, 27, 3379",{},{"id":26,"text":1398,"url":26,"identifiers":1399},"Irani, 2000, Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling, Circ Res, 87, 179, 10.1161\u002F01.RES.87.3.179",{"doi":1400},"10.1161\u002F01.RES.87.3.179",{"id":26,"text":1402,"url":26,"identifiers":1403},"Vavreckova, 1996, Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism, Planta Med, 62, 397, 10.1055\u002Fs-2006-957924",{"doi":1404},"10.1055\u002Fs-2006-957924",{"id":26,"text":1406,"url":26,"identifiers":1407},"Hsieh, 2007, Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells, J Agric Food Chem, 55, 10437, 10.1021\u002Fjf071868c",{"doi":1408},"10.1021\u002Fjf071868c",{"id":26,"text":1410,"url":26,"identifiers":1411},"Liu, 2008, Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose, Arch Biochem Biophys, 475, 128, 10.1016\u002Fj.abb.2008.04.022",{"doi":1412},"10.1016\u002Fj.abb.2008.04.022",{"id":26,"text":1414,"url":26,"identifiers":1415},"Tan, 2007, Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide, Acta Pharmacol Sin, 28, 1914, 10.1111\u002Fj.1745-7254.2007.00705.x",{"doi":1416},"10.1111\u002Fj.1745-7254.2007.00705.x",{"id":26,"text":1418,"url":26,"identifiers":1419},"Yokozawa, 2004, Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components, J Pharm Pharmacol, 56, 547, 10.1211\u002F0022357023024",{"doi":1420},"10.1211\u002F0022357023024",{"id":26,"text":1422,"url":26,"identifiers":1423},"Liu, 2008, Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase, Chin Med J (Engl), 121, 706, 10.1097\u002F00029330-200804020-00009",{"doi":1424},"10.1097\u002F00029330-200804020-00009",{"id":26,"text":1426,"url":26,"identifiers":1427},"Jang, 2009, Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis Chinensis, Arch Pharm Res, 32, 341, 10.1007\u002Fs12272-009-1305-z",{"doi":1428},"10.1007\u002Fs12272-009-1305-z",{"id":26,"text":1430,"url":26,"identifiers":1431},"Meeran, 2008, Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation, Toxicol Appl Pharmacol, 229, 33, 10.1016\u002Fj.taap.2007.12.027",{"doi":1432},"10.1016\u002Fj.taap.2007.12.027",{"id":26,"text":1434,"url":26,"identifiers":1435},"Enk, 2007, Differential effect of Rhizoma coptidis and its main alkaloid compound berberine on TNF-alpha induced NFkappaB translocation in human keratinocytes, J Ethnopharmacol, 109, 170, 10.1016\u002Fj.jep.2006.07.013",{"doi":1436},"10.1016\u002Fj.jep.2006.07.013",{"id":26,"text":1438,"url":26,"identifiers":1439},"Lee, 2007, Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells, Pharmacol Res, 56, 193, 10.1016\u002Fj.phrs.2007.06.003",{"doi":1440},"10.1016\u002Fj.phrs.2007.06.003",{"id":26,"text":1442,"url":26,"identifiers":1443},"Hu, 2008, Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways, Eur J Pharmacol, 580, 70, 10.1016\u002Fj.ejphar.2007.11.013",{"doi":1444},"10.1016\u002Fj.ejphar.2007.11.013",{"id":26,"text":1446,"url":26,"identifiers":1447},"Wartenberg, 2003, Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine, Lab Invest, 83, 87, 10.1097\u002F01.LAB.0000049348.51663.2F",{"doi":1448},"10.1097\u002F01.LAB.0000049348.51663.2F",{"id":26,"text":1450,"url":26,"identifiers":1451},"Lin, 2008, Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro, In Vivo, 22, 223",{},{"id":26,"text":1453,"url":26,"identifiers":1454},"Kim, 2008, Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts, Phytomedicine, 15, 749, 10.1016\u002Fj.phymed.2007.11.004",{"doi":1455},"10.1016\u002Fj.phymed.2007.11.004",{"id":26,"text":1457,"url":26,"identifiers":1458},"Matsuo, 2007, Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells, Cancer Lett, 251, 288, 10.1016\u002Fj.canlet.2006.11.027",{"doi":1459},"10.1016\u002Fj.canlet.2006.11.027",{"id":26,"text":1461,"url":26,"identifiers":1462},"Ho, 2009, Berberine suppresses in vitro migration and invasion of human Scc-4 tongue squamous cancer cells through the inhibitions of Fak, Ikk, Nf-Kappab, U-Pa and Mmp-2 and -9, Cancer Lett, 279, 155, 10.1016\u002Fj.canlet.2009.01.033",{"doi":1463},"10.1016\u002Fj.canlet.2009.01.033",{"id":26,"text":1465,"url":26,"identifiers":1466},"Liu, 2008, Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma, Br J Cancer, 98, 363, 10.1038\u002Fsj.bjc.6604167",{"doi":1467},"10.1038\u002Fsj.bjc.6604167",{"id":26,"text":1469,"url":26,"identifiers":1470},"Yoshino, 1998, Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis, Br J Cancer, 78, 833, 10.1038\u002Fbjc.1998.588",{"doi":1471},"10.1038\u002Fbjc.1998.588",{"id":26,"text":1473,"url":26,"identifiers":1474},"Ichiki, 2000, Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer, Clin Exp Metastasis, 18, 539, 10.1023\u002FA:1011980313237",{"doi":1475},"10.1023\u002FA:1011980313237",{"id":26,"text":1477,"url":26,"identifiers":1478},"Sharom, 2008, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics, 9, 105, 10.2217\u002F14622416.9.1.105",{"doi":1479},"10.2217\u002F14622416.9.1.105",{"id":26,"text":1481,"url":26,"identifiers":1482},"Velamakanni, 2007, ABCG transporters: structure, substrate specificities and physiological roles: a brief overview, J Bioenerg Biomembr, 39, 465, 10.1007\u002Fs10863-007-9122-x",{"doi":1483},"10.1007\u002Fs10863-007-9122-x",{"id":26,"text":1485,"url":26,"identifiers":1486},"Sakai, 2002, Characterization of berberine transport into Coptis japonica cells and the involvement of ABC protein, J Exp Bot, 53, 1879, 10.1093\u002Fjxb\u002Ferf052",{"doi":1487},"10.1093\u002Fjxb\u002Ferf052",{"id":26,"text":1489,"url":26,"identifiers":1490},"Lin, 1999, Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel, Br J Cancer, 81, 416, 10.1038\u002Fsj.bjc.6690710",{"doi":1491},"10.1038\u002Fsj.bjc.6690710",{"id":26,"text":1493,"url":26,"identifiers":1494},"Lin, 1999, Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells, Cancer, 85, 1937, 10.1002\u002F(SICI)1097-0142(19990501)85:9\u003C1937::AID-CNCR9>3.0.CO;2-F",{"doi":1495},"10.1002\u002F(SICI)1097-0142(19990501)85:9\u003C1937::AID-CNCR9>3.0.CO;2-F",{"id":26,"text":1497,"url":26,"identifiers":1498},"Shvarev, 1972, Anti-blastic properties of berberine and its derivatives, Farmakol Toksikol, 35, 73",{},{"id":26,"text":1500,"url":26,"identifiers":1501},"Hoshi, 1976, Antitumor activity of berberrubine derivatives, Gann, 67, 321",{},{"id":26,"text":1503,"url":26,"identifiers":1504},"Nishino, 1986, Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin, Oncology, 43, 131, 10.1159\u002F000226349",{"doi":1505},"10.1159\u002F000226349",{"id":26,"text":1507,"url":26,"identifiers":1508},"Anis, 2001, Inhibition of chemical carcinogenesis by berberine in rats and mice, J Pharm Pharmacol, 53, 763, 10.1211\u002F0022357011775901",{"doi":1509},"10.1211\u002F0022357011775901",{"id":26,"text":1511,"url":26,"identifiers":1512},"Zhang, 1990, Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors, Chin Med J (Engl), 103, 658",{},{"id":26,"text":1514,"url":26,"identifiers":1515},"Jagetia, 2004, Effect of Alstonia scholaris in enhancing the anticancer activity of berberine in the Ehrlich ascites carcinoma-bearing mice, J Med Food, 7, 235, 10.1089\u002F1096620041224094",{"doi":1516},"10.1089\u002F1096620041224094",{"id":26,"text":1518,"url":26,"identifiers":1519},"Peng, 2008, Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death, Int J Radiat Oncol Biol Phys, 70, 529, 10.1016\u002Fj.ijrobp.2007.08.034",{"doi":1520},"10.1016\u002Fj.ijrobp.2007.08.034",{"id":26,"text":1522,"url":26,"identifiers":1523},"Fukutake, 1998, Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon, Biol Pharm Bull, 21, 814, 10.1248\u002Fbpb.21.814",{"doi":1524},"10.1248\u002Fbpb.21.814",{"id":26,"text":1526,"url":26,"identifiers":1527},"Thirupurasundari, 2009, Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats, Chem Biol Interact, 177, 190, 10.1016\u002Fj.cbi.2008.09.027",{"doi":1528},"10.1016\u002Fj.cbi.2008.09.027",{"id":26,"text":1530,"url":26,"identifiers":1531},"Iizuka, 2000, Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6, Cancer Lett, 158, 35, 10.1016\u002FS0304-3835(00)00496-1",{"doi":1532},"10.1016\u002FS0304-3835(00)00496-1",{"id":26,"text":1534,"url":26,"identifiers":1535},"Iizuka, 2002, Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26\u002Fclone 20 adenocarcinoma, Int J Cancer, 99, 286, 10.1002\u002Fijc.10338",{"doi":1536},"10.1002\u002Fijc.10338",{"id":26,"text":1538,"url":26,"identifiers":1539},"Ho, 2009, Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model, Phytomedicine, 16, 887, 10.1016\u002Fj.phymed.2009.02.015",{"doi":1540},"10.1016\u002Fj.phymed.2009.02.015",{"id":26,"text":1542,"url":26,"identifiers":1543},"Harikumar, 2008, Inhibition of progression of erythroleukemia induced by Friend virus in Balb\u002FC mice by natural products-berberine, curcumin and picroliv, J Exp Ther Oncol, 7, 275",{},false,{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1548,"slug":1549,"properties":1550,"entityType":835,"verifyStatus":25,"verifyTime":1547,"verifyNote":837,"syncStatus":28,"languages":1563,"translateLanguages":26,"viewCount":36,"primaryUrl":1564,"fullTextUrl":26,"authors":1565,"publicationType":922,"publisherRelationship":1751,"citationCount":350,"citationInfo":1789,"publishDate":1791,"publishYear":1792,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1793,"isForceReanalyzing":1544},"147d2bca-a4b8-4ba0-93a2-449b79a78f89","2024-11-27T13:36:20.930+00:00",[],"Autophagy-and-doxorubicin-resistance-in-cancer",{"mag":1551,"keywords":1553,"openalex":1554,"abstract":1556,"title":1557,"pm":1559,"doi":1561},{"VOID":1552},"2765420096",{},{"VOID":1555},"W2765420096",{},{"EN":1558},"Autophagy and doxorubicin resistance in cancer",{"VOID":1560},"29099416",{"VOID":1562},"10.1097\u002Fcad.0000000000000572",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-201801000-00001",[1566,1587,1604,1626,1668,1685,1700,1715,1736],{"id":1567,"sortIndex":111,"researcher":26,"roles":1568,"affiliations":1569,"properties":1580},"e012ba1c-9f19-4b28-8e57-d2f5e33de5aa",[],[1570],{"id":1571,"sortIndex":36,"affiliation":1572,"properties":26},"11391da2-19cc-4f59-9f21-d49d91a64555",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1576,"slug":1577,"properties":1578,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"9742fe0a-6a1c-4884-a15b-698a9b0f9599","2024-01-03T08:41:34.778+00:00","2025-02-08T15:23:04.459+00:00",[],"Pathology",{"title":1579},{"VI":1577},{"openalex":1581,"orcid":1583,"title":1585},{"VOID":1582},"A5100647958",{"VOID":1584},"https:\u002F\u002Forcid.org\u002F0000-0002-9431-9244",{"EN":1586},"Hui Yao",{"id":1588,"sortIndex":36,"researcher":26,"roles":1589,"affiliations":1590,"properties":1597},"1ce010e2-69a5-401d-9bd3-a0081d833ddd",[],[1591],{"id":1592,"sortIndex":36,"affiliation":1593,"properties":26},"26cb6865-59b8-4584-a36a-271b0c83d416",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1594,"slug":1577,"properties":1595,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1596},{"VI":1577},{"openalex":1598,"orcid":1600,"title":1602},{"VOID":1599},"A5100408294",{"VOID":1601},"https:\u002F\u002Forcid.org\u002F0000-0001-5259-9324",{"EN":1603},"Chao Chen",{"id":1605,"sortIndex":162,"researcher":26,"roles":1606,"affiliations":1607,"properties":1619},"dcbfde95-fd19-44ed-aa2f-4a5367290a60",[],[1608],{"id":1609,"sortIndex":36,"affiliation":1610,"properties":26},"05a37b11-9017-46cb-b627-57805bf2b46d",{"id":1611,"createTime":1612,"updateTime":1613,"relativeEntities":1614,"slug":1615,"properties":1616,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"05a7e824-ce89-4991-ac8d-d2a68c7bb0da","2024-11-27T13:36:20.986+00:00","2025-06-11T18:48:54.749+00:00",[],"Clinical-Medicine",{"title":1617},{"EN":1618},"Clinical Medicine",{"openalex":1620,"orcid":1622,"title":1624},{"VOID":1621},"A5027518636",{"VOID":1623},"https:\u002F\u002Forcid.org\u002F0000-0002-2594-1072",{"EN":1625},"Di Wu",{"id":1627,"sortIndex":50,"researcher":26,"roles":1628,"affiliations":1629,"properties":1661},"e3c2d973-d545-42f7-bd0f-43cd33060d0c",[],[1630,1640,1650],{"id":1631,"sortIndex":115,"affiliation":1632,"properties":26},"a43dd641-c702-4c0e-9b13-455f67cacdba",{"id":1633,"createTime":1634,"updateTime":1634,"relativeEntities":1635,"slug":1636,"properties":1637,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e907a9ee-7723-489b-a9de-318fc7bca196","2024-11-27T13:36:21.021+00:00",[],"fax-86-731-8887-2260",{"title":1638},{"EN":1639},"fax: +86 731 8887 2260",{"id":1641,"sortIndex":114,"affiliation":1642,"properties":26},"738424f5-5e7b-48ca-b8f9-03d6f32fc345",{"id":1643,"createTime":1644,"updateTime":1644,"relativeEntities":1645,"slug":1646,"properties":1647,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5a3e30be-e0c9-47cf-9c17-76af0d68dec3","2024-11-27T13:36:21.026+00:00",[],"to-Xiyun-Deng-PhD-Department-of-Pathology-Hunan-Normal-University-Changsha-410013-Hunan-Province-China-Tel-86-731-8891-2426",{"title":1648},{"EN":1649},"to Xiyun Deng, PhD, Department of Pathology, Hunan Normal University, Changsha 410013, Hunan Province, China Tel: +86 731 8891 2426",{"id":1651,"sortIndex":36,"affiliation":1652,"properties":26},"0a2be1ee-bc87-4d04-9864-b4b1f6114e0b",{"id":1653,"createTime":1654,"updateTime":1655,"relativeEntities":1656,"slug":1657,"properties":1658,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f8505247-fc80-475b-97e9-35c35aa72209","2024-07-18T05:30:07.704+00:00","2025-02-11T10:07:02.325+00:00",[],"e-mail-email-protected-",{"title":1659},{"EN":1660},"e-mail: [email protected]",{"openalex":1662,"orcid":1664,"title":1666},{"VOID":1663},"A5049487134",{"VOID":1665},"https:\u002F\u002Forcid.org\u002F0000-0003-2203-970X",{"EN":1667},"Xiyun Deng",{"id":1669,"sortIndex":115,"researcher":26,"roles":1670,"affiliations":1671,"properties":1678},"a5d1d2ed-eefa-4037-923b-a872ae5c5afa",[],[1672],{"id":1673,"sortIndex":36,"affiliation":1674,"properties":26},"f5043b3e-f89b-419d-9901-30a85a9650a0",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1675,"slug":1577,"properties":1676,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1677},{"VI":1577},{"openalex":1679,"orcid":1681,"title":1683},{"VOID":1680},"A5100366040",{"VOID":1682},"https:\u002F\u002Forcid.org\u002F0000-0002-9457-0164",{"EN":1684},"Lu Lu",{"id":1686,"sortIndex":135,"researcher":26,"roles":1687,"affiliations":1688,"properties":1695},"f0a466b5-26c2-4d61-9e2b-7c6748964e3d",[],[1689],{"id":1690,"sortIndex":36,"affiliation":1691,"properties":26},"65d9a719-d1b7-4ef2-9894-2f569bca6bda",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1692,"slug":1577,"properties":1693,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1694},{"VI":1577},{"openalex":1696,"title":1698},{"VOID":1697},"A5081908341",{"EN":1699},"Guangchun He",{"id":1701,"sortIndex":114,"researcher":26,"roles":1702,"affiliations":1703,"properties":1710},"219be11f-04b3-41ce-986a-0af6fac7c219",[],[1704],{"id":1705,"sortIndex":36,"affiliation":1706,"properties":26},"e86d35f8-c574-4d00-af7d-48a34d12d2ea",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1707,"slug":1577,"properties":1708,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1709},{"VI":1577},{"openalex":1711,"title":1713},{"VOID":1712},"A5023347866",{"EN":1714},"Shichao Yan",{"id":1716,"sortIndex":158,"researcher":26,"roles":1717,"affiliations":1718,"properties":1729},"b4b442a8-eaa3-447e-879b-965a9373099e",[],[1719],{"id":1720,"sortIndex":36,"affiliation":1721,"properties":26},"502ca86a-25a1-4243-8623-09c3a36024fb",{"id":1722,"createTime":1723,"updateTime":1723,"relativeEntities":1724,"slug":1725,"properties":1726,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"ed60d54e-2d91-4078-8097-35f441e9bb8d","2024-11-27T13:36:21.006+00:00",[],"Pharmacy-Hunan-Normal-University-Medical-College-Changsha-Hunan-Province-China",{"title":1727},{"EN":1728},"Pharmacy, Hunan Normal University Medical College, Changsha, Hunan Province, China",{"openalex":1730,"orcid":1732,"title":1734},{"VOID":1731},"A5030104397",{"VOID":1733},"https:\u002F\u002Forcid.org\u002F0000-0002-3451-9850",{"EN":1735},"Xiaojun Tao",{"id":1737,"sortIndex":59,"researcher":26,"roles":1738,"affiliations":1739,"properties":1746},"fcc0a276-17bf-45d1-8d9d-cc52ab8db134",[],[1740],{"id":1741,"sortIndex":36,"affiliation":1742,"properties":26},"21f6e118-fca4-4f25-84e3-075284abd07c",{"id":1573,"createTime":1574,"updateTime":1575,"relativeEntities":1743,"slug":1577,"properties":1744,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1745},{"VI":1577},{"openalex":1747,"title":1749},{"VOID":1748},"A5019861662",{"EN":1750},"Huimei Yi",{"url":26,"publisher":1752,"properties":1782},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1753,"slug":663,"properties":1754,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1760,"manageAffiliations":1761,"indexDatabases":1762,"url":803,"thumbnailPath":26,"statistic":1777,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":1755,"issn":1756,"introduce":1757,"eissn":1758,"title":1759},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[1763,1770],{"id":762,"indexDatabase":1764,"url":775,"indexYears":776,"academicFieldIds":1769,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":1765,"label":1766,"description":1767,"key":772,"publicationTags":1768,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":1771,"url":799,"indexYears":26,"academicFieldIds":1776,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":1772,"label":1773,"description":1774,"key":795,"publicationTags":1775,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":1778,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":1779,"totalCitation":807,"totalCitationByYear":1780,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":1781,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":1783,"pages":1785,"issue":1787},{"VOID":1784},"29",{"VOID":1786},"1-9",{"VOID":1788},"1",{"total":350,"publishYear":26,"statisticByYear":1790},{"2018":59,"2019":53,"2020":244,"2021":286,"2022":257,"2023":222,"2024":239},"2018-01-01",2018,[1794,1797,1801,1805,1808,1812,1816,1820,1824,1828,1831,1834,1838,1842,1846,1849,1853,1857,1861,1865,1869,1873,1876,1880,1884,1888,1892,1896,1900,1904,1908,1912,1916,1920,1924,1928,1932,1936,1940,1944,1948,1952,1956,1960,1964,1968,1971,1975,1979,1983,1986,1990,1994,1998,2002,2006,2010,2014,2018,2022,2026,2030,2034,2037,2041,2045,2049,2053,2057,2061,2065,2069,2073,2077,2081,2085,2089,2093,2097,2101,2105,2109,2113,2117,2121,2125,2129,2133,2137,2141,2145,2149,2153,2157,2161,2165,2169,2173,2177,2181,2185,2189,2193,2197,2201,2205,2209,2213,2216,2220,2224],{"id":26,"text":1795,"url":26,"identifiers":1796},"Dalton, 1997, Mechanisms of drug resistance in hematologic malignancies, Semin Hematol, 34, 3",{},{"id":26,"text":1798,"url":26,"identifiers":1799},"Young, 2003, Efflux transporters of the human placenta, Adv Drug Deliv Rev, 55, 125, 10.1016\u002FS0169-409X(02)00174-6",{"doi":1800},"10.1016\u002FS0169-409X(02)00174-6",{"id":26,"text":1802,"url":26,"identifiers":1803},"Meredith, 2016, Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism, J Pharm Pharmacol, 68, 729, 10.1111\u002Fjphp.12539",{"doi":1804},"10.1111\u002Fjphp.12539",{"id":26,"text":1806,"url":26,"identifiers":1807},"Ogura, 2001, Adriamycin (doxorubicin), Gan To Kagaku Ryoho, 28, 1331",{},{"id":26,"text":1809,"url":26,"identifiers":1810},"Zhao, 2016, Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance, Sci Rep, 6, 35267, 10.1038\u002Fsrep35267",{"doi":1811},"10.1038\u002Fsrep35267",{"id":26,"text":1813,"url":26,"identifiers":1814},"Kruh, 1993, Doxorubicin and multidrug resistance, Curr Opin Oncol, 5, 1029, 10.1097\u002F00001622-199311000-00014",{"doi":1815},"10.1097\u002F00001622-199311000-00014",{"id":26,"text":1817,"url":26,"identifiers":1818},"Ueda, 1987, The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation, J Biol Chem, 262, 505, 10.1016\u002FS0021-9258(19)75806-2",{"doi":1819},"10.1016\u002FS0021-9258(19)75806-2",{"id":26,"text":1821,"url":26,"identifiers":1822},"Cole, 1992, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science, 258, 1650, 10.1126\u002Fscience.1360704",{"doi":1823},"10.1126\u002Fscience.1360704",{"id":26,"text":1825,"url":26,"identifiers":1826},"Longhurst, 1996, The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line, Br J Cancer, 74, 1331, 10.1038\u002Fbjc.1996.545",{"doi":1827},"10.1038\u002Fbjc.1996.545",{"id":26,"text":1829,"url":26,"identifiers":1830},"Slovak, 1995, The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification, Cancer Res, 55, 4214",{},{"id":26,"text":1832,"url":26,"identifiers":1833},"Wang, 2016, COUP-TFII suppresses colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial–mesenchymal transition, Am J Transl Res, 8, 3921",{},{"id":26,"text":1835,"url":26,"identifiers":1836},"Saxena, 2011, Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters, Cell Death Dis, 2, e179, 10.1038\u002Fcddis.2011.61",{"doi":1837},"10.1038\u002Fcddis.2011.61",{"id":26,"text":1839,"url":26,"identifiers":1840},"Xu, 2017, Resveratrol reverses doxorubicin resistance by inhibiting epithelial–mesenchymal transition (EMT) through modulating PTEN\u002FAkt signaling pathway in gastric cancer, J Exp Clin Cancer Res, 36, 19, 10.1186\u002Fs13046-016-0487-8",{"doi":1841},"10.1186\u002Fs13046-016-0487-8",{"id":26,"text":1843,"url":26,"identifiers":1844},"Xu, 2016, ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial–mesenchymal transition, Cancer Lett, 377, 140, 10.1016\u002Fj.canlet.2016.04.026",{"doi":1845},"10.1016\u002Fj.canlet.2016.04.026",{"id":26,"text":1847,"url":26,"identifiers":1848},"Withoff, 1996, Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review), Anticancer Res, 16, 1867",{},{"id":26,"text":1850,"url":26,"identifiers":1851},"Shukla, 2010, Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin, Mol Cancer, 9, 314, 10.1186\u002F1476-4598-9-314",{"doi":1852},"10.1186\u002F1476-4598-9-314",{"id":26,"text":1854,"url":26,"identifiers":1855},"Singh, 1989, Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells, Biochem Pharmacol, 38, 3505, 10.1016\u002F0006-2952(89)90121-4",{"doi":1856},"10.1016\u002F0006-2952(89)90121-4",{"id":26,"text":1858,"url":26,"identifiers":1859},"Krishna, 2000, Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur J Pharm Sci, 11, 265, 10.1016\u002FS0928-0987(00)00114-7",{"doi":1860},"10.1016\u002FS0928-0987(00)00114-7",{"id":26,"text":1862,"url":26,"identifiers":1863},"Hu, 2016, Mechanisms of drug resistance in colon cancer and its therapeutic strategies, World J Gastroenterol, 22, 6876, 10.3748\u002Fwjg.v22.i30.6876",{"doi":1864},"10.3748\u002Fwjg.v22.i30.6876",{"id":26,"text":1866,"url":26,"identifiers":1867},"Holohan, 2013, Cancer drug resistance: an evolving paradigm, Nat Rev Cancer, 13, 714, 10.1038\u002Fnrc3599",{"doi":1868},"10.1038\u002Fnrc3599",{"id":26,"text":1870,"url":26,"identifiers":1871},"Giacomini, 2010, Membrane transporters in drug development, Nat Rev Drug Discov, 9, 215, 10.1038\u002Fnrd3028",{"doi":1872},"10.1038\u002Fnrd3028",{"id":26,"text":1874,"url":26,"identifiers":1875},"Bogush, 2003, A novel marker of multiple drug resistance BCRP, Antibiot Khimioter, 48, 33",{},{"id":26,"text":1877,"url":26,"identifiers":1878},"Duan, 2015, Potent and selective inhibition of plasma membrane monoamine transporter by HIV Protease inhibitors, Drug Metab Dispos, 43, 1773, 10.1124\u002Fdmd.115.064824",{"doi":1879},"10.1124\u002Fdmd.115.064824",{"id":26,"text":1881,"url":26,"identifiers":1882},"Fernald, 2013, Evading apoptosis in cancer, Trends Cell Biol, 23, 620, 10.1016\u002Fj.tcb.2013.07.006",{"doi":1883},"10.1016\u002Fj.tcb.2013.07.006",{"id":26,"text":1885,"url":26,"identifiers":1886},"Rathore, 2017, Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs), Apoptosis, 22, 898, 10.1007\u002Fs10495-017-1375-1",{"doi":1887},"10.1007\u002Fs10495-017-1375-1",{"id":26,"text":1889,"url":26,"identifiers":1890},"Liu, 2011, DAMP-mediated autophagy contributes to drug resistance, Autophagy, 7, 112, 10.4161\u002Fauto.7.1.14005",{"doi":1891},"10.4161\u002Fauto.7.1.14005",{"id":26,"text":1893,"url":26,"identifiers":1894},"Yan, 2015, Interplay between unfolded protein response and autophagy promotes tumor drug resistance, Oncol Lett, 10, 1959, 10.3892\u002Fol.2015.3508",{"doi":1895},"10.3892\u002Fol.2015.3508",{"id":26,"text":1897,"url":26,"identifiers":1898},"Kumar, 2015, Targeting autophagy to overcome drug resistance in cancer therapy, Future Med Chem, 7, 1535, 10.4155\u002Ffmc.15.88",{"doi":1899},"10.4155\u002Ffmc.15.88",{"id":26,"text":1901,"url":26,"identifiers":1902},"Lin, 2015, Autophagy, cell death, and cancer, Mol Cell Oncol, 2, e985913, 10.4161\u002F23723556.2014.985913",{"doi":1903},"10.4161\u002F23723556.2014.985913",{"id":26,"text":1905,"url":26,"identifiers":1906},"Gottlieb, 2009, Cardioprotection requires taking out the trash, Basic Res Cardiol, 104, 169, 10.1007\u002Fs00395-009-0011-9",{"doi":1907},"10.1007\u002Fs00395-009-0011-9",{"id":26,"text":1909,"url":26,"identifiers":1910},"Glick, 2010, Autophagy: cellular and molecular mechanisms, J Pathol, 221, 3, 10.1002\u002Fpath.2697",{"doi":1911},"10.1002\u002Fpath.2697",{"id":26,"text":1913,"url":26,"identifiers":1914},"Parzych, 2014, An overview of autophagy: morphology, mechanism, and regulation, Antioxid Redox Signal, 20, 460, 10.1089\u002Fars.2013.5371",{"doi":1915},"10.1089\u002Fars.2013.5371",{"id":26,"text":1917,"url":26,"identifiers":1918},"Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038\u002Fnature06639",{"doi":1919},"10.1038\u002Fnature06639",{"id":26,"text":1921,"url":26,"identifiers":1922},"Subramani, 2013, Non-autophagic roles of autophagy-related proteins, EMBO Rep, 14, 143, 10.1038\u002Fembor.2012.220",{"doi":1923},"10.1038\u002Fembor.2012.220",{"id":26,"text":1925,"url":26,"identifiers":1926},"Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016\u002Fj.cell.2007.12.018",{"doi":1927},"10.1016\u002Fj.cell.2007.12.018",{"id":26,"text":1929,"url":26,"identifiers":1930},"Yang, 2010, Eaten alive: a history of macroautophagy, Nat Cell Biol, 12, 814, 10.1038\u002Fncb0910-814",{"doi":1931},"10.1038\u002Fncb0910-814",{"id":26,"text":1933,"url":26,"identifiers":1934},"Dirks-Naylor, 2013, The role of autophagy in doxorubicin-induced cardiotoxicity, Life Sci, 93, 913, 10.1016\u002Fj.lfs.2013.10.013",{"doi":1935},"10.1016\u002Fj.lfs.2013.10.013",{"id":26,"text":1937,"url":26,"identifiers":1938},"Thorburn, 2014, Autophagy and cancer therapy, Mol Pharmacol, 85, 830, 10.1124\u002Fmol.114.091850",{"doi":1939},"10.1124\u002Fmol.114.091850",{"id":26,"text":1941,"url":26,"identifiers":1942},"Lekli, 2017, Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia\u002Freperfusion-associated cardiac arrhythmias, J Cell Mol Med, 21, 1058, 10.1111\u002Fjcmm.13053",{"doi":1943},"10.1111\u002Fjcmm.13053",{"id":26,"text":1945,"url":26,"identifiers":1946},"Ganley, 2011, Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest, Mol Cell, 42, 731, 10.1016\u002Fj.molcel.2011.04.024",{"doi":1947},"10.1016\u002Fj.molcel.2011.04.024",{"id":26,"text":1949,"url":26,"identifiers":1950},"Martinez-Outschoorn, 2010, The autophagic tumor stroma model of cancer or ‘battery-operated tumor growth’: a simple solution to the autophagy paradox, Cell Cycle, 9, 4297, 10.4161\u002Fcc.9.21.13817",{"doi":1951},"10.4161\u002Fcc.9.21.13817",{"id":26,"text":1953,"url":26,"identifiers":1954},"Guo, 2016, Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells, BMC Cancer, 16, 762, 10.1186\u002Fs12885-016-2790-3",{"doi":1955},"10.1186\u002Fs12885-016-2790-3",{"id":26,"text":1957,"url":26,"identifiers":1958},"Huang, 2016, Stress management by autophagy: Implications for chemoresistance, Int J Cancer, 139, 23, 10.1002\u002Fijc.29990",{"doi":1959},"10.1002\u002Fijc.29990",{"id":26,"text":1961,"url":26,"identifiers":1962},"Lin, 2010, Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer, Mol Cancer Res, 8, 1217, 10.1158\u002F1541-7786.MCR-10-0162",{"doi":1963},"10.1158\u002F1541-7786.MCR-10-0162",{"id":26,"text":1965,"url":26,"identifiers":1966},"Sui, 2013, Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, Cell Death Dis, 4, e838, 10.1038\u002Fcddis.2013.350",{"doi":1967},"10.1038\u002Fcddis.2013.350",{"id":26,"text":1969,"url":26,"identifiers":1970},"Ren, 2016, Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer, Biochim Biophys Acta, 1866, 266",{},{"id":26,"text":1972,"url":26,"identifiers":1973},"Li, 2017, Autophagy and multidrug resistance in cancer, Chin J Cancer, 36, 52, 10.1186\u002Fs40880-017-0219-2",{"doi":1974},"10.1186\u002Fs40880-017-0219-2",{"id":26,"text":1976,"url":26,"identifiers":1977},"Pan, 2015, Autophagy in drug resistance of the multiple myeloma cell line RPMI8226 to doxorubicin, Genet Mol Res, 14, 5621, 10.4238\u002F2015.May.25.14",{"doi":1978},"10.4238\u002F2015.May.25.14",{"id":26,"text":1980,"url":26,"identifiers":1981},"Tan, 2015, Src\u002FSTAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy, Cancer Sci, 106, 1023, 10.1111\u002Fcas.12712",{"doi":1982},"10.1111\u002Fcas.12712",{"id":26,"text":1984,"url":26,"identifiers":1985},"Ma, 2015, Rapamycin-mediated mTOR inhibition reverses drug resistance to adriamycin in colon cancer cells, Hepatogastroenterology, 62, 880",{},{"id":26,"text":1987,"url":26,"identifiers":1988},"Yousefi, 2006, Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis, Nat Cell Biol, 8, 1124, 10.1038\u002Fncb1482",{"doi":1989},"10.1038\u002Fncb1482",{"id":26,"text":1991,"url":26,"identifiers":1992},"Yang, 2013, Application and interpretation of current autophagy inhibitors and activators, Acta Pharmacol Sin, 34, 625, 10.1038\u002Faps.2013.5",{"doi":1993},"10.1038\u002Faps.2013.5",{"id":26,"text":1995,"url":26,"identifiers":1996},"Pasquier, 2016, Autophagy inhibitors, Cell Mol Life Sci, 73, 985, 10.1007\u002Fs00018-015-2104-y",{"doi":1997},"10.1007\u002Fs00018-015-2104-y",{"id":26,"text":1999,"url":26,"identifiers":2000},"Towers, 2016, Therapeutic targeting of autophagy, EBioMedicine, 14, 15, 10.1016\u002Fj.ebiom.2016.10.034",{"doi":2001},"10.1016\u002Fj.ebiom.2016.10.034",{"id":26,"text":2003,"url":26,"identifiers":2004},"Wang, 2016, Pharmacological inhibitors of autophagy as novel cancer therapeutic agents, Pharmacol Res, 105, 164, 10.1016\u002Fj.phrs.2016.01.028",{"doi":2005},"10.1016\u002Fj.phrs.2016.01.028",{"id":26,"text":2007,"url":26,"identifiers":2008},"Aydinlik, 2017, Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line, Biochim Biophys Acta, 1861, 49, 10.1016\u002Fj.bbagen.2016.11.013",{"doi":2009},"10.1016\u002Fj.bbagen.2016.11.013",{"id":26,"text":2011,"url":26,"identifiers":2012},"Majeski, 2004, Mechanisms of chaperone-mediated autophagy, Int J Biochem Cell Biol, 36, 2435, 10.1016\u002Fj.biocel.2004.02.013",{"doi":2013},"10.1016\u002Fj.biocel.2004.02.013",{"id":26,"text":2015,"url":26,"identifiers":2016},"Massey, 2004, Pathophysiology of chaperone-mediated autophagy, Int J Biochem Cell Biol, 36, 2420, 10.1016\u002Fj.biocel.2004.04.010",{"doi":2017},"10.1016\u002Fj.biocel.2004.04.010",{"id":26,"text":2019,"url":26,"identifiers":2020},"Saha, 2012, LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy, Autophagy, 8, 1643, 10.4161\u002Fauto.21654",{"doi":2021},"10.4161\u002Fauto.21654",{"id":26,"text":2023,"url":26,"identifiers":2024},"Giovane, 1994, Net, a new ets transcription factor that is activated by Ras, Genes Dev, 8, 1502, 10.1101\u002Fgad.8.13.1502",{"doi":2025},"10.1101\u002Fgad.8.13.1502",{"id":26,"text":2027,"url":26,"identifiers":2028},"Park, 2016, PI3K\u002FAkt\u002FmTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy, Biochem Biophys Res Commun, 477, 277, 10.1016\u002Fj.bbrc.2016.06.057",{"doi":2029},"10.1016\u002Fj.bbrc.2016.06.057",{"id":26,"text":2031,"url":26,"identifiers":2032},"Kang, 2007, Relationship of serum adiponectin and resistin levels with breast cancer risk, J Korean Med Sci, 22, 117, 10.3346\u002Fjkms.2007.22.1.117",{"doi":2033},"10.3346\u002Fjkms.2007.22.1.117",{"id":26,"text":2035,"url":26,"identifiers":2036},"Liu, 2017, Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction, Am J Cancer Res, 7, 574",{},{"id":26,"text":2038,"url":26,"identifiers":2039},"Tang, 2010, Endogenous HMGB1 regulates autophagy, J Cell Biol, 190, 881, 10.1083\u002Fjcb.200911078",{"doi":2040},"10.1083\u002Fjcb.200911078",{"id":26,"text":2042,"url":26,"identifiers":2043},"Liu, 2011, HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells, Leukemia, 25, 23, 10.1038\u002Fleu.2010.225",{"doi":2044},"10.1038\u002Fleu.2010.225",{"id":26,"text":2046,"url":26,"identifiers":2047},"Huang, 2012, HMGB1 promotes drug resistance in osteosarcoma, Cancer Res, 72, 230, 10.1158\u002F0008-5472.CAN-11-2001",{"doi":2048},"10.1158\u002F0008-5472.CAN-11-2001",{"id":26,"text":2050,"url":26,"identifiers":2051},"Xu, 2016, MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy, Oncol Rep, 35, 1757, 10.3892\u002For.2015.4497",{"doi":2052},"10.3892\u002For.2015.4497",{"id":26,"text":2054,"url":26,"identifiers":2055},"Chen, 2017, MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma, Mol Med Rep, 15, 1326, 10.3892\u002Fmmr.2017.6149",{"doi":2056},"10.3892\u002Fmmr.2017.6149",{"id":26,"text":2058,"url":26,"identifiers":2059},"Chang, 2014, Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro, ScientificWorldJournal, 2014, 794756, 10.1155\u002F2014\u002F794756",{"doi":2060},"10.1155\u002F2014\u002F794756",{"id":26,"text":2062,"url":26,"identifiers":2063},"Wang, 2017, Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy, Oncotarget, 8, 31465, 10.18632\u002Foncotarget.16356",{"doi":2064},"10.18632\u002Foncotarget.16356",{"id":26,"text":2066,"url":26,"identifiers":2067},"Jia, 2009, Current evaluation of the millennium phytomedicine- ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine, Curr Med Chem, 16, 2924, 10.2174\u002F092986709788803204",{"doi":2068},"10.2174\u002F092986709788803204",{"id":26,"text":2070,"url":26,"identifiers":2071},"Kim, 2014, 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin, Oncotarget, 5, 4438, 10.18632\u002Foncotarget.2034",{"doi":2072},"10.18632\u002Foncotarget.2034",{"id":26,"text":2074,"url":26,"identifiers":2075},"Stauffer, 2007, Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737, Curr Top Med Chem, 7, 961, 10.2174\u002F156802607780906843",{"doi":2076},"10.2174\u002F156802607780906843",{"id":26,"text":2078,"url":26,"identifiers":2079},"Levine, 2008, Bcl-2 family members: dual regulators of apoptosis and autophagy, Autophagy, 4, 600, 10.4161\u002Fauto.6260",{"doi":2080},"10.4161\u002Fauto.6260",{"id":26,"text":2082,"url":26,"identifiers":2083},"Yao, 2017, B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells, Tumour Biol, 39, 1010428317695965, 10.1177\u002F1010428317695965",{"doi":2084},"10.1177\u002F1010428317695965",{"id":26,"text":2086,"url":26,"identifiers":2087},"Jin, 2017, MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy, Cell Death Dis, 8, e2540, 10.1038\u002Fcddis.2016.461",{"doi":2088},"10.1038\u002Fcddis.2016.461",{"id":26,"text":2090,"url":26,"identifiers":2091},"Hagenbuchner, 2016, Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma, Oncotarget, 7, 77591, 10.18632\u002Foncotarget.12728",{"doi":2092},"10.18632\u002Foncotarget.12728",{"id":26,"text":2094,"url":26,"identifiers":2095},"Salcher, 2017, C10ORF10\u002FDEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy, Mol Cancer, 16, 95, 10.1186\u002Fs12943-017-0661-4",{"doi":2096},"10.1186\u002Fs12943-017-0661-4",{"id":26,"text":2098,"url":26,"identifiers":2099},"Bolden, 2006, Anticancer activities of histone deacetylase inhibitors, Nat Rev Drug Discov, 5, 769, 10.1038\u002Fnrd2133",{"doi":2100},"10.1038\u002Fnrd2133",{"id":26,"text":2102,"url":26,"identifiers":2103},"Oehme, 2013, Histone deacetylase 10 promotes autophagy-mediated cell survival, Proc Natl Acad Sci USA, 110, E2592, 10.1073\u002Fpnas.1300113110",{"doi":2104},"10.1073\u002Fpnas.1300113110",{"id":26,"text":2106,"url":26,"identifiers":2107},"Suh, 2013, A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer, Cancer Lett, 332, 102, 10.1016\u002Fj.canlet.2013.01.022",{"doi":2108},"10.1016\u002Fj.canlet.2013.01.022",{"id":26,"text":2110,"url":26,"identifiers":2111},"Li, 2014, Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells, Oncol Lett, 8, 1603, 10.3892\u002Fol.2014.2368",{"doi":2112},"10.3892\u002Fol.2014.2368",{"id":26,"text":2114,"url":26,"identifiers":2115},"Thamilselvan, 2011, Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 beta\u002Fbeta-catenin pathway, Int J Cancer, 129, 2916, 10.1002\u002Fijc.25949",{"doi":2116},"10.1002\u002Fijc.25949",{"id":26,"text":2118,"url":26,"identifiers":2119},"Cheng, 2013, Acquired multidrug resistance in human K562\u002FADM cells is associated with enhanced autophagy, Toxicol Mech Methods, 23, 678, 10.3109\u002F15376516.2013.843105",{"doi":2120},"10.3109\u002F15376516.2013.843105",{"id":26,"text":2122,"url":26,"identifiers":2123},"Sardiello, 2009, A gene network regulating lysosomal biogenesis and function, Science, 325, 473, 10.1126\u002Fscience.1174447",{"doi":2124},"10.1126\u002Fscience.1174447",{"id":26,"text":2126,"url":26,"identifiers":2127},"Fang, 2017, Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells, Acta Pharmacol Sin, 38, 1305, 10.1038\u002Faps.2017.25",{"doi":2128},"10.1038\u002Faps.2017.25",{"id":26,"text":2130,"url":26,"identifiers":2131},"Seca, 2013, Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells, Curr Drug Targets, 14, 1135, 10.2174\u002F13894501113149990185",{"doi":2132},"10.2174\u002F13894501113149990185",{"id":26,"text":2134,"url":26,"identifiers":2135},"Nicholson, 2001, EGFR and cancer prognosis, Eur J Cancer, 37, S9, 10.1016\u002FS0959-8049(01)00231-3",{"doi":2136},"10.1016\u002FS0959-8049(01)00231-3",{"id":26,"text":2138,"url":26,"identifiers":2139},"Xu, 2011, Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin, Prostate, 71, 1216, 10.1002\u002Fpros.21337",{"doi":2140},"10.1002\u002Fpros.21337",{"id":26,"text":2142,"url":26,"identifiers":2143},"Westhoff, 2013, Sequential dosing in chemosensitization: targeting the PI3K\u002FAkt\u002FmTOR pathway in neuroblastoma, PLoS One, 8, e83128, 10.1371\u002Fjournal.pone.0083128",{"doi":2144},"10.1371\u002Fjournal.pone.0083128",{"id":26,"text":2146,"url":26,"identifiers":2147},"Lin, 2009, Autophagy: a new target for advanced papillary thyroid cancer therapy, Surgery, 146, 1208, 10.1016\u002Fj.surg.2009.09.019",{"doi":2148},"10.1016\u002Fj.surg.2009.09.019",{"id":26,"text":2150,"url":26,"identifiers":2151},"Kim, 2015, Psammaplin A induces sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7\u002Fadr human breast cancer cells and xenografts, Biochim Biophys Acta, 1850, 401, 10.1016\u002Fj.bbagen.2014.11.007",{"doi":2152},"10.1016\u002Fj.bbagen.2014.11.007",{"id":26,"text":2154,"url":26,"identifiers":2155},"Meschini, 2007, Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells, Toxicol In Vitro, 21, 197, 10.1016\u002Fj.tiv.2006.09.007",{"doi":2156},"10.1016\u002Fj.tiv.2006.09.007",{"id":26,"text":2158,"url":26,"identifiers":2159},"Meschini, 2008, The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells, Autophagy, 4, 1020, 10.4161\u002Fauto.6952",{"doi":2160},"10.4161\u002Fauto.6952",{"id":26,"text":2162,"url":26,"identifiers":2163},"Meijer, 1997, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5, Eur J Biochem, 243, 527, 10.1111\u002Fj.1432-1033.1997.t01-2-00527.x",{"doi":2164},"10.1111\u002Fj.1432-1033.1997.t01-2-00527.x",{"id":26,"text":2166,"url":26,"identifiers":2167},"Lambert, 2008, Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model, Cancer Res, 68, 7966, 10.1158\u002F0008-5472.CAN-08-1333",{"doi":2168},"10.1158\u002F0008-5472.CAN-08-1333",{"id":26,"text":2170,"url":26,"identifiers":2171},"Gao, 2017, Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition, J Liposome Res, 27, 151, 10.1080\u002F08982104.2016.1185731",{"doi":2172},"10.1080\u002F08982104.2016.1185731",{"id":26,"text":2174,"url":26,"identifiers":2175},"Tuteja, 2014, High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm, Clin Pharmacol Ther, 96, 48, 10.1038\u002Fclpt.2014.79",{"doi":2176},"10.1038\u002Fclpt.2014.79",{"id":26,"text":2178,"url":26,"identifiers":2179},"Wang, 2014, Combination of apolipoprotein A1-modi liposome-doxorubicin with autophagy inhibitors overcame drug resistance in vitro, J Pharm Sci, 103, 3994, 10.1002\u002Fjps.24216",{"doi":2180},"10.1002\u002Fjps.24216",{"id":26,"text":2182,"url":26,"identifiers":2183},"Saiyin, 2014, Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy, Mol Pharm, 11, 1662, 10.1021\u002Fmp5000423",{"doi":2184},"10.1021\u002Fmp5000423",{"id":26,"text":2186,"url":26,"identifiers":2187},"Hua, 2017, Seeking new anti-cancer agents from autophagy-regulating natural products, J Asian Nat Prod Res, 19, 305, 10.1080\u002F10286020.2017.1304385",{"doi":2188},"10.1080\u002F10286020.2017.1304385",{"id":26,"text":2190,"url":26,"identifiers":2191},"Sun, 2016, Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells, Biomaterials, 103, 44, 10.1016\u002Fj.biomaterials.2016.06.038",{"doi":2192},"10.1016\u002Fj.biomaterials.2016.06.038",{"id":26,"text":2194,"url":26,"identifiers":2195},"Satoh, 2006, Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives, J Pharmacol Sci, 100, 513, 10.1254\u002Fjphs.CPJ06002X",{"doi":2196},"10.1254\u002Fjphs.CPJ06002X",{"id":26,"text":2198,"url":26,"identifiers":2199},"Wei, 2010, C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy, Nanotechnology, 21, 495101, 10.1088\u002F0957-4484\u002F21\u002F49\u002F495101",{"doi":2200},"10.1088\u002F0957-4484\u002F21\u002F49\u002F495101",{"id":26,"text":2202,"url":26,"identifiers":2203},"Zhang, 2009, Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal, Autophagy, 5, 1107, 10.4161\u002Fauto.5.8.9842",{"doi":2204},"10.4161\u002Fauto.5.8.9842",{"id":26,"text":2206,"url":26,"identifiers":2207},"Youle, 2008, The BCL-2 protein family: opposing activities that mediate cell death, Nat Rev Mol Cell Biol, 9, 47, 10.1038\u002Fnrm2308",{"doi":2208},"10.1038\u002Fnrm2308",{"id":26,"text":2210,"url":26,"identifiers":2211},"Buchholz, 2003, Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy, Cancer J, 9, 33, 10.1097\u002F00130404-200301000-00007",{"doi":2212},"10.1097\u002F00130404-200301000-00007",{"id":26,"text":2214,"url":26,"identifiers":2215},"Tabuchi, 2009, Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer, Int J Oncol, 34, 313",{},{"id":26,"text":2217,"url":26,"identifiers":2218},"Tekedereli, 2013, Therapeutic silencing of Bcl-2 by systemically administered siRNA nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in orthotopic xenograft models of ER (−) and ER (+) breast cancer, Mol Ther Nucleic Acids, 2, e121, 10.1038\u002Fmtna.2013.45",{"doi":2219},"10.1038\u002Fmtna.2013.45",{"id":26,"text":2221,"url":26,"identifiers":2222},"Broxterman, 2009, Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib, Drug Resist Updat, 12, 114, 10.1016\u002Fj.drup.2009.07.001",{"doi":2223},"10.1016\u002Fj.drup.2009.07.001",{"id":26,"text":2225,"url":26,"identifiers":2226},"Shi, 2017, Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation, Cell Discov, 3, 17010, 10.1038\u002Fcelldisc.2017.10",{"doi":2227},"10.1038\u002Fcelldisc.2017.10",{"id":2229,"createTime":2230,"updateTime":2230,"relativeEntities":2231,"slug":2232,"properties":2233,"entityType":835,"verifyStatus":28,"verifyTime":2246,"verifyNote":2247,"syncStatus":28,"languages":2248,"translateLanguages":26,"viewCount":36,"primaryUrl":2249,"fullTextUrl":26,"authors":2250,"publicationType":922,"publisherRelationship":2394,"citationCount":2430,"citationInfo":2431,"publishDate":2433,"publishYear":965,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2434,"isForceReanalyzing":1544},"e1dfbb37-1f64-403f-a1e1-db65cb0b9aa5","2024-11-29T14:33:03.131+00:00",[],"PI3K-Akt-is-involved-in-bufalin-induced-apoptosis-in-gastric-cancer-cells",{"mag":2234,"keywords":2236,"openalex":2237,"abstract":2239,"title":2240,"pm":2242,"doi":2244},{"VOID":2235},"2017981926",{},{"VOID":2238},"W2017981926",{},{"EN":2241},"PI3K\u002FAkt is involved in bufalin-induced apoptosis in gastric cancer cells",{"VOID":2243},"19343001",{"VOID":2245},"10.1097\u002Fcad.0b013e3283160fd6","2024-11-29T14:33:03.130+00:00","Author affiliation is blank",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-200901000-00008",[2251,2273,2290,2305,2322,2339,2366,2377],{"id":2252,"sortIndex":59,"researcher":26,"roles":2253,"affiliations":2254,"properties":2266},"99e3bc1e-4898-4887-8417-0c12f8c33325",[],[2255],{"id":2256,"sortIndex":36,"affiliation":2257,"properties":26},"c0a471d4-76c9-4d85-bd31-a8ea25bd8092",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2261,"slug":2262,"properties":2263,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"43f983c1-2099-48be-ae9f-7cfc46871a38","2024-04-11T13:27:00.046+00:00","2024-11-29T14:33:03.151+00:00",[],"Department-of-Medical-Oncology-The-First-Hospital-China-Medical-University-Shenyang-China",{"title":2264},{"EN":2265},"Department of Medical Oncology, The First Hospital, China Medical University, Shenyang, China",{"openalex":2267,"orcid":2269,"title":2271},{"VOID":2268},"A5100449362",{"VOID":2270},"https:\u002F\u002Forcid.org\u002F0009-0000-4883-8097",{"EN":2272},"Ye Zhang",{"id":2274,"sortIndex":36,"researcher":26,"roles":2275,"affiliations":2276,"properties":2283},"d6752583-001e-43fb-8828-11f7eac155a5",[],[2277],{"id":2278,"sortIndex":36,"affiliation":2279,"properties":26},"7d593efe-093c-4431-83ae-6d628d84dd87",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2280,"slug":2262,"properties":2281,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2282},{"EN":2265},{"openalex":2284,"orcid":2286,"title":2288},{"VOID":2285},"A5100380671",{"VOID":2287},"https:\u002F\u002Forcid.org\u002F0000-0001-7351-5548",{"EN":2289},"Dan Li",{"id":2291,"sortIndex":114,"researcher":26,"roles":2292,"affiliations":2293,"properties":2300},"d9834129-a61e-41a9-8ccf-ba91e9253bde",[],[2294],{"id":2295,"sortIndex":36,"affiliation":2296,"properties":26},"9d703e24-a034-4e61-b746-d9a10d63e8cf",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2297,"slug":2262,"properties":2298,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2299},{"EN":2265},{"openalex":2301,"title":2303},{"VOID":2302},"A5103857419",{"EN":2304},"Kezuo Hou",{"id":2306,"sortIndex":135,"researcher":26,"roles":2307,"affiliations":2308,"properties":2315},"74eabc41-4c33-4ad6-95de-03fbaf53e244",[],[2309],{"id":2310,"sortIndex":36,"affiliation":2311,"properties":26},"402e45b3-c4d8-4d74-88de-2f5cc1f614c4",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2312,"slug":2262,"properties":2313,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2314},{"EN":2265},{"openalex":2316,"orcid":2318,"title":2320},{"VOID":2317},"A5100769089",{"VOID":2319},"https:\u002F\u002Forcid.org\u002F0000-0002-0711-2764",{"EN":2321},"Jingdong Zhang",{"id":2323,"sortIndex":162,"researcher":26,"roles":2324,"affiliations":2325,"properties":2332},"ae7612e6-d91d-4115-b983-1264445e7b6e",[],[2326],{"id":2327,"sortIndex":36,"affiliation":2328,"properties":26},"2124eafb-35b3-4245-8957-66d586afdd3d",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2329,"slug":2262,"properties":2330,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2331},{"EN":2265},{"openalex":2333,"orcid":2335,"title":2337},{"VOID":2334},"A5078066178",{"VOID":2336},"https:\u002F\u002Forcid.org\u002F0000-0002-9198-9795",{"EN":2338},"Yuee Teng",{"id":2340,"sortIndex":158,"researcher":26,"roles":2341,"affiliations":2342,"properties":2359},"6b80e71c-4d2c-473c-a737-ce8c566bae2b",[],[2343,2349],{"id":2344,"sortIndex":36,"affiliation":2345,"properties":26},"65f19007-aad9-4a8e-848f-fee9dee30171",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2346,"slug":2262,"properties":2347,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2348},{"EN":2265},{"id":2350,"sortIndex":115,"affiliation":2351,"properties":26},"99064e2e-5b2c-45c0-ab75-ce75451ba1e8",{"id":2352,"createTime":2353,"updateTime":2353,"relativeEntities":2354,"slug":2355,"properties":2356,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7494e0d2-ca97-4799-9b0c-e6bd032e6ca3","2024-11-29T14:33:03.320+00:00",[],"to-Yunpeng-Liu-MD-PhD-Department-of-Medical-Oncology-the-First-Hospital-China-Medical-University-NO-155-North-Nanjing-Street-Heping-District-Shenyang-110001-China",{"title":2357},{"EN":2358},"to Yunpeng Liu, MD, PhD, Department of Medical Oncology, the First Hospital, China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang 110001, China",{"openalex":2360,"orcid":2362,"title":2364},{"VOID":2361},"A5081310064",{"VOID":2363},"https:\u002F\u002Forcid.org\u002F0000-0001-9800-4373",{"EN":2365},"Yunpeng Liu",{"id":2367,"sortIndex":115,"researcher":26,"roles":2368,"affiliations":2369,"properties":2370},"cb172658-9830-4832-a4d9-42186ee06993",[],[],{"openalex":2371,"orcid":2373,"title":2375},{"VOID":2372},"A5006455181",{"VOID":2374},"https:\u002F\u002Forcid.org\u002F0009-0005-9366-2314",{"EN":2376},"Xiujuan Qu",{"id":2378,"sortIndex":111,"researcher":26,"roles":2379,"affiliations":2380,"properties":2387},"8d55232f-d406-488c-bc18-77f9ceea845f",[],[2381],{"id":2382,"sortIndex":36,"affiliation":2383,"properties":26},"93207b4c-85c0-4350-8515-6c1270271c24",{"id":2258,"createTime":2259,"updateTime":2260,"relativeEntities":2384,"slug":2262,"properties":2385,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2386},{"EN":2265},{"openalex":2388,"orcid":2390,"title":2392},{"VOID":2389},"A5101665486",{"VOID":2391},"https:\u002F\u002Forcid.org\u002F0009-0005-5588-3044",{"EN":2393},"Qian Dong",{"url":26,"publisher":2395,"properties":2425},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2396,"slug":663,"properties":2397,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2403,"manageAffiliations":2404,"indexDatabases":2405,"url":803,"thumbnailPath":26,"statistic":2420,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":2398,"issn":2399,"introduce":2400,"eissn":2401,"title":2402},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[2406,2413],{"id":762,"indexDatabase":2407,"url":775,"indexYears":776,"academicFieldIds":2412,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":2408,"label":2409,"description":2410,"key":772,"publicationTags":2411,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":2414,"url":799,"indexYears":26,"academicFieldIds":2419,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":2415,"label":2416,"description":2417,"key":795,"publicationTags":2418,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":2421,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":2422,"totalCitation":807,"totalCitationByYear":2423,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":2424,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":2426,"pages":2427,"issue":2429},{"VOID":956},{"VOID":2428},"59-64",{"VOID":1788},154,{"total":2430,"publishYear":26,"statisticByYear":2432},{"2012":52,"2013":298,"2014":52,"2015":124,"2016":53,"2017":356,"2018":242,"2019":53,"2020":50,"2021":53,"2022":111,"2023":111,"2024":158},"2009-01-01",[2435,2439,2443,2447,2451,2455,2459,2462,2465,2468,2472,2476,2479,2483,2487,2491,2495,2499,2503,2507,2511,2514,2518,2522,2526,2530,2534,2537,2541,2545,2549,2552,2556],{"id":26,"text":2436,"url":26,"identifiers":2437},"Parkin, 1999, Global cancer statistics, CA Cancer J Clin, 49, 33, 10.3322\u002Fcanjclin.49.1.33",{"doi":2438},"10.3322\u002Fcanjclin.49.1.33",{"id":26,"text":2440,"url":26,"identifiers":2441},"Krenn, 1998, Bufadienolides from animal and plant sources, Phytochemistry, 48, 1, 10.1016\u002FS0031-9422(97)00426-3",{"doi":2442},"10.1016\u002FS0031-9422(97)00426-3",{"id":26,"text":2444,"url":26,"identifiers":2445},"Masuda, 1995, Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells, Leuk Res, 19, 549, 10.1016\u002F0145-2126(95)00031-I",{"doi":2446},"10.1016\u002F0145-2126(95)00031-I",{"id":26,"text":2448,"url":26,"identifiers":2449},"Yin, 2007, Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines, Acta Pharmacol Sin, 28, 712, 10.1111\u002Fj.1745-7254.2007.00559.x",{"doi":2450},"10.1111\u002Fj.1745-7254.2007.00559.x",{"id":26,"text":2452,"url":26,"identifiers":2453},"Yeh, 2003, Effect of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells, Prostate, 54, 112, 10.1002\u002Fpros.10172",{"doi":2454},"10.1002\u002Fpros.10172",{"id":26,"text":2456,"url":26,"identifiers":2457},"Watabe, 1996, The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells, J Biol Chem, 271, 14067, 10.1074\u002Fjbc.271.24.14067",{"doi":2458},"10.1074\u002Fjbc.271.24.14067",{"id":26,"text":2460,"url":26,"identifiers":2461},"Tian, 2006, Downregulation of Bcl-2 and survivin expression and release of Smac\u002FDIABLO involved in bufalin-induced HL-60 cell apoptosis, Zhonghua Xue Ye Xue Za Zhi, 27, 21",{},{"id":26,"text":2463,"url":26,"identifiers":2464},"Liu, 2002, WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin, Zhonghua Xue Ye Xue Za Zhi, 23, 356",{},{"id":26,"text":2466,"url":26,"identifiers":2467},"Tian, 2007, Effect of bufalin-inducing apoptosis on Bcl-2 and PKC in HL-60 cells, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 15, 67",{},{"id":26,"text":2469,"url":26,"identifiers":2470},"Brunet, 2001, Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a), Mol Cell Biol, 21, 952, 10.1128\u002FMCB.21.3.952-965.2001",{"doi":2471},"10.1128\u002FMCB.21.3.952-965.2001",{"id":26,"text":2473,"url":26,"identifiers":2474},"Yuan, 2000, Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\u002FAkt pathway in human ovarian cancer, Oncogene, 19, 2324, 10.1038\u002Fsj.onc.1203598",{"doi":2475},"10.1038\u002Fsj.onc.1203598",{"id":26,"text":2477,"url":26,"identifiers":2478},"Page, 2000, Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells, Int J Oncol, 17, 23",{},{"id":26,"text":2480,"url":26,"identifiers":2481},"Hemmings, 1997, Akt signaling: linking membrane events to life and death decisions, Science, 275, 628, 10.1126\u002Fscience.275.5300.628",{"doi":2482},"10.1126\u002Fscience.275.5300.628",{"id":26,"text":2484,"url":26,"identifiers":2485},"Cardone, 1998, Regulation of cell death protease caspase-9 by phosphorylation, Science, 282, 1318, 10.1126\u002Fscience.282.5392.1318",{"doi":2486},"10.1126\u002Fscience.282.5392.1318",{"id":26,"text":2488,"url":26,"identifiers":2489},"Ozes, 1999, NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase, Nature, 401, 82, 10.1038\u002F43466",{"doi":2490},"10.1038\u002F43466",{"id":26,"text":2492,"url":26,"identifiers":2493},"El-Rayes, 2006, Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB, Cancer Res, 66, 10553, 10.1158\u002F0008-5472.CAN-06-2333",{"doi":2494},"10.1158\u002F0008-5472.CAN-06-2333",{"id":26,"text":2496,"url":26,"identifiers":2497},"Kwon, 2007, A polysaccharide of the marine alga Capsosiphon fulvescens induces apoptosis in AGS gastric cancer cells via an IGF-IR-mediated PI3K\u002FAkt pathway, Cell Biol Int, 31, 768, 10.1016\u002Fj.cellbi.2007.01.010",{"doi":2498},"10.1016\u002Fj.cellbi.2007.01.010",{"id":26,"text":2500,"url":26,"identifiers":2501},"Moon, 2008, Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells, Toxicon, 51, 112, 10.1016\u002Fj.toxicon.2007.08.015",{"doi":2502},"10.1016\u002Fj.toxicon.2007.08.015",{"id":26,"text":2504,"url":26,"identifiers":2505},"Watabe, 1998, Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells, Oncogene, 16, 779, 10.1038\u002Fsj.onc.1201592",{"doi":2506},"10.1038\u002Fsj.onc.1201592",{"id":26,"text":2508,"url":26,"identifiers":2509},"Kawazoe, 1999, Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells, Oncogene, 18, 2413, 10.1038\u002Fsj.onc.1202555",{"doi":2510},"10.1038\u002Fsj.onc.1202555",{"id":26,"text":2512,"url":26,"identifiers":2513},"Jing, 1994, Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells, Anticancer Res, 14, 1193",{},{"id":26,"text":2515,"url":26,"identifiers":2516},"Dreesen, 2007, Signaling pathways in cancer and embryonic stem cells, Stem Cell Rev, 3, 7, 10.1007\u002Fs12015-007-0004-8",{"doi":2517},"10.1007\u002Fs12015-007-0004-8",{"id":26,"text":2519,"url":26,"identifiers":2520},"Jeong, 2008, PI3K\u002FAKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells, Virology, 370, 264, 10.1016\u002Fj.virol.2007.09.003",{"doi":2521},"10.1016\u002Fj.virol.2007.09.003",{"id":26,"text":2523,"url":26,"identifiers":2524},"Fan, 2006, Inhibition of Akt\u002FPKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells, Digestion, 73, 75, 10.1159\u002F000092747",{"doi":2525},"10.1159\u002F000092747",{"id":26,"text":2527,"url":26,"identifiers":2528},"Ostrakhovitch, 2005, Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: the lack of effect of ERK in p53 mediated copper induced apoptosis, J Cell Biochem, 95, 1120, 10.1002\u002Fjcb.20484",{"doi":2529},"10.1002\u002Fjcb.20484",{"id":26,"text":2531,"url":26,"identifiers":2532},"Kang, 2000, The inhibition of ERK\u002FMAPK not the activation of JNK\u002FSAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells, Leuk Res, 24, 527, 10.1016\u002FS0145-2126(00)00010-2",{"doi":2533},"10.1016\u002FS0145-2126(00)00010-2",{"id":26,"text":2535,"url":26,"identifiers":2536},"Wang, 2006, Bufalin-induced apoptosis through inhibition of ERK signal and downregulation of TOPO-αα in K562 cells, Chinese J Cancer Prev Treat, 22, 1701",{},{"id":26,"text":2538,"url":26,"identifiers":2539},"Kyo, 2003, Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation, Genes Cells, 8, 825, 10.1046\u002Fj.1365-2443.2003.00679.x",{"doi":2540},"10.1046\u002Fj.1365-2443.2003.00679.x",{"id":26,"text":2542,"url":26,"identifiers":2543},"Qu, 2004, Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b, Blood, 103, 1779, 10.1182\u002Fblood-2003-07-2260",{"doi":2544},"10.1182\u002Fblood-2003-07-2260",{"id":26,"text":2546,"url":26,"identifiers":2547},"Thien, 2005, c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses, Biochem J, 391, 153, 10.1042\u002FBJ20050892",{"doi":2548},"10.1042\u002FBJ20050892",{"id":26,"text":2550,"url":26,"identifiers":2551},"Sattler, 1996, The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\u002FABL and p210BCR\u002FABL to the phosphatidylinositol-3' kinase pathway, Oncogene, 12, 839",{},{"id":26,"text":2553,"url":26,"identifiers":2554},"Fang, 2001, Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells, Nat Immunol, 2, 870, 10.1038\u002Fni0901-870",{"doi":2555},"10.1038\u002Fni0901-870",{"id":26,"text":2557,"url":26,"identifiers":2558},"Qu, 2008, Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation, Biochem Biophys Res Commun, 367, 183, 10.1016\u002Fj.bbrc.2007.12.120",{"doi":2559},"10.1016\u002Fj.bbrc.2007.12.120",{"id":2561,"createTime":2562,"updateTime":2562,"relativeEntities":2563,"slug":2564,"properties":2565,"entityType":835,"verifyStatus":25,"verifyTime":2562,"verifyNote":837,"syncStatus":28,"languages":2578,"translateLanguages":26,"viewCount":36,"primaryUrl":2579,"fullTextUrl":26,"authors":2580,"publicationType":922,"publisherRelationship":2631,"citationCount":2669,"citationInfo":2670,"publishDate":2672,"publishYear":2673,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2674,"isForceReanalyzing":1544},"5d480735-eeb8-47d6-b7a7-bb3311932931","2024-09-27T13:06:49.801+00:00",[],"Apoptosis-based-drug-screening-and-detection-of-selective-toxicity-to-cancer-cells",{"mag":2566,"keywords":2568,"openalex":2569,"abstract":2571,"title":2572,"pm":2574,"doi":2576},{"VOID":2567},"2005490888",{},{"VOID":2570},"W2005490888",{},{"EN":2573},"Apoptosis-based drug screening and detection of selective toxicity to cancer cells",{"VOID":2575},"12960740",{"VOID":2577},"10.1097\u002F00001813-200308000-00008",[102],"http:\u002F\u002Fjournals.lww.com\u002F00001813-200308000-00008",[2581,2610],{"id":2582,"sortIndex":115,"researcher":26,"roles":2583,"affiliations":2584,"properties":2605},"e5040411-4358-4aa7-8382-b07a6b08736c",[],[2585,2595],{"id":2586,"sortIndex":115,"affiliation":2587,"properties":26},"3548ff8f-90bd-4241-b6ff-12bfc13c86d0",{"id":2588,"createTime":2589,"updateTime":2589,"relativeEntities":2590,"slug":2591,"properties":2592,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1d7c3a47-b068-4a1f-8e68-57d37f608d83","2024-09-27T13:06:49.821+00:00",[],"to-O-Frankfurt-Radiation-Oncology-Department-R-71-PAP-Building-Room-128-University-of-Miami-Medical-School-1550-NW-10th-Avenue-Miami-FL-33136-USA",{"title":2593},{"EN":2594},"to O. Frankfurt, Radiation Oncology Department (R-71), PAP Building, Room 128, University of Miami Medical School, 1550 NW 10th Avenue, Miami, FL 33136, USA",{"id":2596,"sortIndex":36,"affiliation":2597,"properties":26},"bbc7f7b3-4251-4014-9119-10c114e65b68",{"id":2598,"createTime":2599,"updateTime":2599,"relativeEntities":2600,"slug":2601,"properties":2602,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a1c40e05-26e6-4981-a0ba-657d2cea2ca2","2024-09-27T13:06:49.817+00:00",[],"Sponsorship-This-work-was-supported-by-grant-CA83508-from-the-National-Cancer-Institute-",{"title":2603},{"EN":2604},"Sponsorship: This work was supported by grant CA83508 from the National Cancer Institute.",{"openalex":2606,"title":2608},{"VOID":2607},"A5016655943",{"EN":2609},"Awtar Krishan",{"id":2611,"sortIndex":36,"researcher":26,"roles":2612,"affiliations":2613,"properties":2626},"f60d6f77-3e0c-486d-a9a3-ebe922495d44",[],[2614,2620],{"id":2615,"sortIndex":36,"affiliation":2616,"properties":26},"70a9fc7f-11a4-46f2-8b93-8789e95ad510",{"id":2598,"createTime":2599,"updateTime":2599,"relativeEntities":2617,"slug":2601,"properties":2618,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2619},{"EN":2604},{"id":2621,"sortIndex":115,"affiliation":2622,"properties":26},"b85d0cd3-73bb-49ef-8109-9b41dd4c1fe6",{"id":2588,"createTime":2589,"updateTime":2589,"relativeEntities":2623,"slug":2591,"properties":2624,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2625},{"EN":2594},{"openalex":2627,"title":2629},{"VOID":2628},"A5091681401",{"EN":2630},"Oskar S. Frankfurt",{"url":26,"publisher":2632,"properties":2662},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2633,"slug":663,"properties":2634,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2640,"manageAffiliations":2641,"indexDatabases":2642,"url":803,"thumbnailPath":26,"statistic":2657,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":2635,"issn":2636,"introduce":2637,"eissn":2638,"title":2639},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[2643,2650],{"id":762,"indexDatabase":2644,"url":775,"indexYears":776,"academicFieldIds":2649,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":2645,"label":2646,"description":2647,"key":772,"publicationTags":2648,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":2651,"url":799,"indexYears":26,"academicFieldIds":2656,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":2652,"label":2653,"description":2654,"key":795,"publicationTags":2655,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":2658,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":2659,"totalCitation":807,"totalCitationByYear":2660,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":2661,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":2663,"pages":2665,"issue":2667},{"VOID":2664},"14",{"VOID":2666},"555-561",{"VOID":2668},"7",130,{"total":2669,"publishYear":26,"statisticByYear":2671},{"2012":52,"2013":116,"2014":116,"2015":135,"2016":53,"2017":135,"2018":52,"2019":162,"2020":158,"2021":52,"2023":114,"2024":114},"2003-08-01",2003,[2675,2679,2683,2686,2690,2694,2698,2701,2705,2708,2712,2716,2720,2724,2728,2732,2736,2739,2743,2747,2751,2755,2758,2762,2766],{"id":26,"text":2676,"url":26,"identifiers":2677},"Balis, 2002, J Natl Cancer Inst, 94, 78, 10.1093\u002Fjnci\u002F94.2.78",{"doi":2678},"10.1093\u002Fjnci\u002F94.2.78",{"id":26,"text":2680,"url":26,"identifiers":2681},"Dunstan, 2002, J Natl Cancer Inst, 94, 88, 10.1093\u002Fjnci\u002F94.2.88",{"doi":2682},"10.1093\u002Fjnci\u002F94.2.88",{"id":26,"text":2684,"url":26,"identifiers":2685},"Vassilev, 2001, Anticancer Drug Des, 16, 7",{},{"id":26,"text":2687,"url":26,"identifiers":2688},"Frankfurt, 2003, Chem-Biol Interact, 145, 89, 10.1016\u002FS0009-2797(02)00241-7",{"doi":2689},"10.1016\u002FS0009-2797(02)00241-7",{"id":26,"text":2691,"url":26,"identifiers":2692},"Johnson, 2001, Br J Cancer, 84, 1424, 10.1054\u002Fbjoc.2001.1796",{"doi":2693},"10.1054\u002Fbjoc.2001.1796",{"id":26,"text":2695,"url":26,"identifiers":2696},"Trielli, 1996, J Cell Biol, 135, 689, 10.1083\u002Fjcb.135.3.689",{"doi":2697},"10.1083\u002Fjcb.135.3.689",{"id":26,"text":2699,"url":26,"identifiers":2700},"Lu, 2000, Cancer Res, 60, 6465",{},{"id":26,"text":2702,"url":26,"identifiers":2703},"Quto, 2002, Cancer Chemother Pharmacol, 49, 167, 10.1007\u002Fs00280-001-0403-5",{"doi":2704},"10.1007\u002Fs00280-001-0403-5",{"id":26,"text":2706,"url":26,"identifiers":2707},"Howells, 2002, Mol Cancer Ther, 1, 1161",{},{"id":26,"text":2709,"url":26,"identifiers":2710},"Woynarowska, 2002, Biochim Biophys Acta, 1587, 309, 10.1016\u002FS0925-4439(02)00094-7",{"doi":2711},"10.1016\u002FS0925-4439(02)00094-7",{"id":26,"text":2713,"url":26,"identifiers":2714},"Blajeski, 2001, Exp Cell Res, 270, 277, 10.1006\u002Fexcr.2001.5349",{"doi":2715},"10.1006\u002Fexcr.2001.5349",{"id":26,"text":2717,"url":26,"identifiers":2718},"Frankfurt, 1996, Exp Cell Res, 226, 387, 10.1006\u002Fexcr.1996.0240",{"doi":2719},"10.1006\u002Fexcr.1996.0240",{"id":26,"text":2721,"url":26,"identifiers":2722},"Frankfurt, 2001, J Histochem Cytochem, 49, 369, 10.1177\u002F002215540104900311",{"doi":2723},"10.1177\u002F002215540104900311",{"id":26,"text":2725,"url":26,"identifiers":2726},"Frankfurt, 2001, J Immunol Methods, 253, 133, 10.1016\u002FS0022-1759(01)00387-8",{"doi":2727},"10.1016\u002FS0022-1759(01)00387-8",{"id":26,"text":2729,"url":26,"identifiers":2730},"Zamzani, 1999, Nature, 401, 127, 10.1038\u002F43591",{"doi":2731},"10.1038\u002F43591",{"id":26,"text":2733,"url":26,"identifiers":2734},"Monks, 1991, J Natl Cancer Inst, 83, 757, 10.1093\u002Fjnci\u002F83.11.757",{"doi":2735},"10.1093\u002Fjnci\u002F83.11.757",{"id":26,"text":2737,"url":26,"identifiers":2738},"Carmichael, 1987, Cancer Res, 47, 936",{},{"id":26,"text":2740,"url":26,"identifiers":2741},"Sheers, 2001, Toxicol In Vitro, 15, 153, 10.1016\u002FS0887-2333(00)00062-X",{"doi":2742},"10.1016\u002FS0887-2333(00)00062-X",{"id":26,"text":2744,"url":26,"identifiers":2745},"Evans, 2001, Toxicol In Vitro, 15, 579, 10.1016\u002FS0887-2333(01)00064-9",{"doi":2746},"10.1016\u002FS0887-2333(01)00064-9",{"id":26,"text":2748,"url":26,"identifiers":2749},"Senderowicz, 2000, J Natl Cancer Inst, 92, 376, 10.1093\u002Fjnci\u002F92.5.376",{"doi":2750},"10.1093\u002Fjnci\u002F92.5.376",{"id":26,"text":2752,"url":26,"identifiers":2753},"Koornstra, 2003, Crit Rev Oncol Hematol, 45, 37, 10.1016\u002FS1040-8428(01)00228-1",{"doi":2754},"10.1016\u002FS1040-8428(01)00228-1",{"id":26,"text":2756,"url":26,"identifiers":2757},"Frankfurt, 1997, Clinical Cancer Res, 3, 465",{},{"id":26,"text":2759,"url":26,"identifiers":2760},"Pestell, 2000, Mol Pharmacol, 57, 503, 10.1124\u002Fmol.57.3.503",{"doi":2761},"10.1124\u002Fmol.57.3.503",{"id":26,"text":2763,"url":26,"identifiers":2764},"Mathiasen, 2002, Trends Mol Med, 8, 212, 10.1016\u002FS1471-4914(02)02328-6",{"doi":2765},"10.1016\u002FS1471-4914(02)02328-6",{"id":26,"text":2767,"url":26,"identifiers":2768},"Alonso, 2003, Mol Cancer Ther, 2, 139, 10.4161\u002Fcbt.214",{"doi":2769},"10.4161\u002Fcbt.214",{"id":2771,"createTime":2772,"updateTime":2772,"relativeEntities":2773,"slug":2774,"properties":2775,"entityType":835,"verifyStatus":25,"verifyTime":2772,"verifyNote":837,"syncStatus":28,"languages":2788,"translateLanguages":26,"viewCount":36,"primaryUrl":2789,"fullTextUrl":26,"authors":2790,"publicationType":922,"publisherRelationship":2947,"citationCount":126,"citationInfo":2983,"publishDate":2985,"publishYear":2986,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2987,"isForceReanalyzing":1544},"f6ab2508-ccf6-4db0-b56c-cd011aaa3f17","2024-10-01T04:59:50.626+00:00",[],"Chlorogenic-acid-induces-reactive-oxygen-species-generation-and-inhibits-the-viability-of-human-colon-cancer-cells",{"mag":2776,"keywords":2778,"openalex":2779,"abstract":2781,"title":2782,"pm":2784,"doi":2786},{"VOID":2777},"2516701631",{},{"VOID":2780},"W2516701631",{},{"EN":2783},"Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells",{"VOID":2785},"27603595",{"VOID":2787},"10.1097\u002Fcad.0000000000000430",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-201701000-00006",[2791,2832,2861,2890,2919],{"id":2792,"sortIndex":114,"researcher":26,"roles":2793,"affiliations":2794,"properties":2825},"ef3ea8a7-8594-4ec4-88d9-d57a50b48877",[],[2795,2805,2815],{"id":2796,"sortIndex":115,"affiliation":2797,"properties":26},"9d8fd834-9da4-497a-ad22-8873d02b59ed",{"id":2798,"createTime":2799,"updateTime":2799,"relativeEntities":2800,"slug":2801,"properties":2802,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6b7cd87b-6876-4c49-b705-e415142616a9","2024-10-01T04:59:50.649+00:00",[],"bDepartment-of-General-Surgery-the-Second-Affiliated-Hospital-of-Xi-an-Jiaotong-University-Xi-an",{"title":2803},{"EN":2804},"bDepartment of General Surgery, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an",{"id":2806,"sortIndex":36,"affiliation":2807,"properties":26},"bfcc64ce-55c4-4ad8-9419-615c75cbfc2a",{"id":2808,"createTime":2809,"updateTime":2809,"relativeEntities":2810,"slug":2811,"properties":2812,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"adc45b3f-6d54-41ad-bbcb-0d3348663938","2024-10-01T04:59:50.644+00:00",[],"aDepartment-of-Cell-Biology-and-Genetics-School-of-Basic-Medical-Sciences-Xi-an-Jiaotong-University-Health-Science-Center",{"title":2813},{"EN":2814},"aDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center",{"id":2816,"sortIndex":114,"affiliation":2817,"properties":26},"5e37c6fc-2868-40c4-bc42-ab25f176ee74",{"id":2818,"createTime":2819,"updateTime":2819,"relativeEntities":2820,"slug":2821,"properties":2822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b7b551ef-45ba-493d-b4ce-f41010e818fb","2024-10-01T04:59:50.654+00:00",[],"cDepartment-of-Gastroenterology-Xi-an-Central-Hospital-Shaanxi-China",{"title":2823},{"EN":2824},"cDepartment of Gastroenterology, Xi’an Central Hospital, Shaanxi, China",{"openalex":2826,"orcid":2828,"title":2830},{"VOID":2827},"A5102799580",{"VOID":2829},"https:\u002F\u002Forcid.org\u002F0000-0002-3535-4285",{"EN":2831},"Jia Han",{"id":2833,"sortIndex":36,"researcher":26,"roles":2834,"affiliations":2835,"properties":2854},"8414e9ca-d5bd-4f39-8c00-9428600ac1ca",[],[2836,2842,2848],{"id":2837,"sortIndex":114,"affiliation":2838,"properties":26},"1246773b-8f98-4abd-bb9f-b2b88a774707",{"id":2818,"createTime":2819,"updateTime":2819,"relativeEntities":2839,"slug":2821,"properties":2840,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2841},{"EN":2824},{"id":2843,"sortIndex":115,"affiliation":2844,"properties":26},"eccd4c31-c7bd-4207-aa66-6a0496450098",{"id":2798,"createTime":2799,"updateTime":2799,"relativeEntities":2845,"slug":2801,"properties":2846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2847},{"EN":2804},{"id":2849,"sortIndex":36,"affiliation":2850,"properties":26},"12a606bb-647f-41d9-b677-46fea6908c3c",{"id":2808,"createTime":2809,"updateTime":2809,"relativeEntities":2851,"slug":2811,"properties":2852,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2853},{"EN":2814},{"openalex":2855,"orcid":2857,"title":2859},{"VOID":2856},"A5103216427",{"VOID":2858},"https:\u002F\u002Forcid.org\u002F0000-0002-4721-6525",{"EN":2860},"Ni Hou",{"id":2862,"sortIndex":115,"researcher":26,"roles":2863,"affiliations":2864,"properties":2883},"97f27413-0a13-4f06-8d26-b80830cdc1ef",[],[2865,2871,2877],{"id":2866,"sortIndex":36,"affiliation":2867,"properties":26},"7fba5f05-4882-4c4b-83b7-3db897c0ac50",{"id":2808,"createTime":2809,"updateTime":2809,"relativeEntities":2868,"slug":2811,"properties":2869,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2870},{"EN":2814},{"id":2872,"sortIndex":115,"affiliation":2873,"properties":26},"afc84bf0-226a-4a08-a270-416209af663a",{"id":2798,"createTime":2799,"updateTime":2799,"relativeEntities":2874,"slug":2801,"properties":2875,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2876},{"EN":2804},{"id":2878,"sortIndex":114,"affiliation":2879,"properties":26},"6302613a-74c9-4f61-a50b-82476cfbc040",{"id":2818,"createTime":2819,"updateTime":2819,"relativeEntities":2880,"slug":2821,"properties":2881,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2882},{"EN":2824},{"openalex":2884,"orcid":2886,"title":2888},{"VOID":2885},"A5100389806",{"VOID":2887},"https:\u002F\u002Forcid.org\u002F0000-0003-3246-9674",{"EN":2889},"Na Liu",{"id":2891,"sortIndex":59,"researcher":26,"roles":2892,"affiliations":2893,"properties":2912},"aa2f5eb5-4359-45c2-8dc8-25086032bfca",[],[2894,2900,2906],{"id":2895,"sortIndex":115,"affiliation":2896,"properties":26},"1f6d1459-5e64-439a-bcb6-fb7a09a5a7b2",{"id":2798,"createTime":2799,"updateTime":2799,"relativeEntities":2897,"slug":2801,"properties":2898,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2899},{"EN":2804},{"id":2901,"sortIndex":114,"affiliation":2902,"properties":26},"b5efb078-6754-425a-ab93-0edb5c291cbd",{"id":2818,"createTime":2819,"updateTime":2819,"relativeEntities":2903,"slug":2821,"properties":2904,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2905},{"EN":2824},{"id":2907,"sortIndex":36,"affiliation":2908,"properties":26},"6032ca89-2928-44ee-b996-50c3e148c4a8",{"id":2808,"createTime":2809,"updateTime":2809,"relativeEntities":2909,"slug":2811,"properties":2910,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2911},{"EN":2814},{"openalex":2913,"orcid":2915,"title":2917},{"VOID":2914},"A5024439801",{"VOID":2916},"https:\u002F\u002Forcid.org\u002F0009-0001-0808-4996",{"EN":2918},"Yan Yuan",{"id":2920,"sortIndex":111,"researcher":26,"roles":2921,"affiliations":2922,"properties":2940},"32096487-f841-4561-af62-5405bf5801e3",[],[2923,2934],{"id":2924,"sortIndex":115,"affiliation":2925,"properties":26},"8bf99e2e-2fcf-4091-9c10-0c1e14b81763",{"id":2926,"createTime":2927,"updateTime":2928,"relativeEntities":2929,"slug":2930,"properties":2931,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"01bf1c16-f6fb-4818-9537-0243f350ce38","2024-10-01T04:59:50.696+00:00","2025-06-11T15:11:27.742+00:00",[],"to-Jie-Li-MD-PhD-Department-of-General-Surgery-the-Second-Affiliated-Hospital-of-Xi-an-Jiaotong-University-West-5-Road-Xi-an-710004-Shaanxi-Province-China-Tel-fax-86-29-87679851",{"title":2932},{"EN":2933},"to Jie Li, MD, PhD, Department of General Surgery, the Second Affiliated Hospital of Xi’an Jiaotong University, West 5 Road, Xi’an 710004, Shaanxi Province, China Tel\u002Ffax: +86 29 87679851",{"id":2935,"sortIndex":36,"affiliation":2936,"properties":26},"168ceb17-e3f9-4249-a4ce-6f8b7766d18c",{"id":1653,"createTime":1654,"updateTime":1655,"relativeEntities":2937,"slug":1657,"properties":2938,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2939},{"EN":1660},{"openalex":2941,"orcid":2943,"title":2945},{"VOID":2942},"A5100740418",{"VOID":2944},"https:\u002F\u002Forcid.org\u002F0000-0001-7602-7654",{"EN":2946},"Jie Li",{"url":26,"publisher":2948,"properties":2978},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2949,"slug":663,"properties":2950,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2956,"manageAffiliations":2957,"indexDatabases":2958,"url":803,"thumbnailPath":26,"statistic":2973,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":2951,"issn":2952,"introduce":2953,"eissn":2954,"title":2955},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[2959,2966],{"id":762,"indexDatabase":2960,"url":775,"indexYears":776,"academicFieldIds":2965,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":2961,"label":2962,"description":2963,"key":772,"publicationTags":2964,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":2967,"url":799,"indexYears":26,"academicFieldIds":2972,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":2968,"label":2969,"description":2970,"key":795,"publicationTags":2971,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":2974,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":2975,"totalCitation":807,"totalCitationByYear":2976,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":2977,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":2979,"pages":2980,"issue":2982},{"VOID":815},{"VOID":2981},"59-65",{"VOID":1788},{"total":126,"publishYear":26,"statisticByYear":2984},{"2017":111,"2018":50,"2019":50,"2020":237,"2021":222,"2022":242,"2023":173,"2024":53},"2017-01-01",2017,[2988,2992,2996,3000,3004,3008,3012,3016,3020,3024,3028,3032,3036,3040,3044,3048,3052,3056,3060,3064,3068,3072,3076,3080,3084,3088,3092,3096,3100,3104],{"id":26,"text":2989,"url":26,"identifiers":2990},"Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322\u002Fcaac.20107",{"doi":2991},"10.3322\u002Fcaac.20107",{"id":26,"text":2993,"url":26,"identifiers":2994},"Kanavos, 2006, The rising burden of cancer in the developing world, Ann Oncol, 17, viii15, 10.1093\u002Fannonc\u002Fmdl983",{"doi":2995},"10.1093\u002Fannonc\u002Fmdl983",{"id":26,"text":2997,"url":26,"identifiers":2998},"Arab, 2010, Epidemiologic evidence on coffee and cancer, Nutr Cancer, 62, 271, 10.1080\u002F01635580903407122",{"doi":2999},"10.1080\u002F01635580903407122",{"id":26,"text":3001,"url":26,"identifiers":3002},"Sinha, 2012, Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study, Am J Clin Nutr, 96, 374, 10.3945\u002Fajcn.111.031328",{"doi":3003},"10.3945\u002Fajcn.111.031328",{"id":26,"text":3005,"url":26,"identifiers":3006},"Je, 2009, Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies, Int J Cancer, 124, 1662, 10.1002\u002Fijc.24124",{"doi":3007},"10.1002\u002Fijc.24124",{"id":26,"text":3009,"url":26,"identifiers":3010},"Clifford, 1999, Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden, J Sci Food Agric, 79, 362, 10.1002\u002F(SICI)1097-0010(19990301)79:3\u003C362::AID-JSFA256>3.0.CO;2-D",{"doi":3011},"10.1002\u002F(SICI)1097-0010(19990301)79:3\u003C362::AID-JSFA256>3.0.CO;2-D",{"id":26,"text":3013,"url":26,"identifiers":3014},"Olthof, 2001, Chlorogenic acid and caffeic acid are absorbed in humans, J Nutr, 131, 66, 10.1093\u002Fjn\u002F131.1.66",{"doi":3015},"10.1093\u002Fjn\u002F131.1.66",{"id":26,"text":3017,"url":26,"identifiers":3018},"Kono, 1997, Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen, Biochim Biophys Acta, 1335, 335, 10.1016\u002FS0304-4165(96)00151-1",{"doi":3019},"10.1016\u002FS0304-4165(96)00151-1",{"id":26,"text":3021,"url":26,"identifiers":3022},"Johnston, 2003, Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine, Am J Clin Nutr, 78, 728, 10.1093\u002Fajcn\u002F78.4.728",{"doi":3023},"10.1093\u002Fajcn\u002F78.4.728",{"id":26,"text":3025,"url":26,"identifiers":3026},"Stich, 1982, Inhibition of mutagenicity of a model nitrosation reaction by naturally occurring phenolics, coffee and tea, Mutat Res, 95, 119, 10.1016\u002F0027-5107(82)90251-2",{"doi":3027},"10.1016\u002F0027-5107(82)90251-2",{"id":26,"text":3029,"url":26,"identifiers":3030},"Volz, 2012, Effect of coffee combining green coffee bean constituents with typical roasting products on the Nrf2\u002FARE pathway in vitro and in vivo, J Agric Food Chem, 60, 9631, 10.1021\u002Fjf302258u",{"doi":3031},"10.1021\u002Fjf302258u",{"id":26,"text":3033,"url":26,"identifiers":3034},"Xavier, 2012, Hypericum androsaemum water extract inhibits proliferation in human colorectal cancer cells through effects on MAP kinases and PI3K\u002FAkt pathway, Food Funct, 3, 844, 10.1039\u002Fc2fo10226a",{"doi":3035},"10.1039\u002Fc2fo10226a",{"id":26,"text":3037,"url":26,"identifiers":3038},"Hou, 2008, Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases, Endocrinology, 149, 1654, 10.1210\u002Fen.2007-0988",{"doi":3039},"10.1210\u002Fen.2007-0988",{"id":26,"text":3041,"url":26,"identifiers":3042},"Yamamoto, 2008, Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity, Mol Cell Biol, 28, 2758, 10.1128\u002FMCB.01704-07",{"doi":3043},"10.1128\u002FMCB.01704-07",{"id":26,"text":3045,"url":26,"identifiers":3046},"Burhans, 2009, The cell cycle is a redox cycle: linking phase-specific targets to cell fate, Free Radic Biol Med, 47, 1282, 10.1016\u002Fj.freeradbiomed.2009.05.026",{"doi":3047},"10.1016\u002Fj.freeradbiomed.2009.05.026",{"id":26,"text":3049,"url":26,"identifiers":3050},"Dhillon, 2007, MAP kinase signalling pathways in cancer, Oncogene, 26, 3279, 10.1038\u002Fsj.onc.1210421",{"doi":3051},"10.1038\u002Fsj.onc.1210421",{"id":26,"text":3053,"url":26,"identifiers":3054},"Lee, 2000, Sustained activation of Ras\u002FRaf\u002Fmitogen-activated protein kinase cascade by the tumor suppressor p53, Proc Natl Acad Sci USA, 97, 8302, 10.1073\u002Fpnas.150024397",{"doi":3055},"10.1073\u002Fpnas.150024397",{"id":26,"text":3057,"url":26,"identifiers":3058},"Fan, 2014, Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling, Oncotarget, 5, 2853, 10.18632\u002Foncotarget.1854",{"doi":3059},"10.18632\u002Foncotarget.1854",{"id":26,"text":3061,"url":26,"identifiers":3062},"Yun, 2012, Protective effects of chlorogenic acid against ischemia\u002Freperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties, J Nutr Biochem, 23, 1249, 10.1016\u002Fj.jnutbio.2011.06.018",{"doi":3063},"10.1016\u002Fj.jnutbio.2011.06.018",{"id":26,"text":3065,"url":26,"identifiers":3066},"Shi, 2013, Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells, Inflamm Res, 62, 581, 10.1007\u002Fs00011-013-0610-7",{"doi":3067},"10.1007\u002Fs00011-013-0610-7",{"id":26,"text":3069,"url":26,"identifiers":3070},"Zhao, 2012, Antihypertensive effects and mechanisms of chlorogenic acids, Hypertens Res, 35, 370, 10.1038\u002Fhr.2011.195",{"doi":3071},"10.1038\u002Fhr.2011.195",{"id":26,"text":3073,"url":26,"identifiers":3074},"Shi, 2009, Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats, Eur J Pharmacol, 623, 119, 10.1016\u002Fj.ejphar.2009.09.026",{"doi":3075},"10.1016\u002Fj.ejphar.2009.09.026",{"id":26,"text":3077,"url":26,"identifiers":3078},"Feng, 2005, Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid, J Biol Chem, 280, 27888, 10.1074\u002Fjbc.M503347200",{"doi":3079},"10.1074\u002Fjbc.M503347200",{"id":26,"text":3081,"url":26,"identifiers":3082},"Belkaid, 2006, The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression, Cancer Cell Int, 6, 7, 10.1186\u002F1475-2867-6-7",{"doi":3083},"10.1186\u002F1475-2867-6-7",{"id":26,"text":3085,"url":26,"identifiers":3086},"Burgos-Morón, 2012, The coffee constituent chlorogenic acid induces cellular DNA damage and formation of topoisomerase I- and II-DNA complexes in cells, J Agric Food Chem, 60, 7384, 10.1021\u002Fjf300999e",{"doi":3087},"10.1021\u002Fjf300999e",{"id":26,"text":3089,"url":26,"identifiers":3090},"Yan, 2015, Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases, Anticancer Drugs, 26, 540, 10.1097\u002FCAD.0000000000000218",{"doi":3091},"10.1097\u002FCAD.0000000000000218",{"id":26,"text":3093,"url":26,"identifiers":3094},"Akhdar, 2009, Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells, Eur J Cancer, 45, 2219, 10.1016\u002Fj.ejca.2009.05.017",{"doi":3095},"10.1016\u002Fj.ejca.2009.05.017",{"id":26,"text":3097,"url":26,"identifiers":3098},"Sporn, 2012, NRF2 and cancer: the good, the bad and the importance of context, Nat Rev Cancer, 12, 564, 10.1038\u002Fnrc3278",{"doi":3099},"10.1038\u002Fnrc3278",{"id":26,"text":3101,"url":26,"identifiers":3102},"Willis, 2009, Regulation of DNA replication by the S-phase DNA damage checkpoint, Cell Div, 4, 13, 10.1186\u002F1747-1028-4-13",{"doi":3103},"10.1186\u002F1747-1028-4-13",{"id":26,"text":3105,"url":26,"identifiers":3106},"Wu, 2006, ERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR function, Oncogene, 25, 1153, 10.1038\u002Fsj.onc.1209148",{"doi":3107},"10.1038\u002Fsj.onc.1209148",{"id":3109,"createTime":3110,"updateTime":3110,"relativeEntities":3111,"slug":3112,"properties":3113,"entityType":835,"verifyStatus":28,"verifyTime":3110,"verifyNote":2247,"syncStatus":28,"languages":3126,"translateLanguages":26,"viewCount":36,"primaryUrl":3127,"fullTextUrl":26,"authors":3128,"publicationType":922,"publisherRelationship":3198,"citationCount":3236,"citationInfo":3237,"publishDate":3239,"publishYear":3240,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3241,"isForceReanalyzing":1544},"e93b2a71-1fe4-449a-a355-b14a5a25d1e9","2024-09-18T15:55:19.069+00:00",[],"Evaluation-of-synthetic-reconstituted-high-density-lipoproteins-as-delivery-vehicles-for-paclitaxel",{"mag":3114,"keywords":3116,"openalex":3117,"abstract":3119,"title":3120,"pm":3122,"doi":3124},{"VOID":3115},"2014360391",{},{"VOID":3118},"W2014360391",{},{"EN":3121},"Evaluation of synthetic\u002Freconstituted high-density lipoproteins as delivery vehicles for paclitaxel",{"VOID":3123},"18176115",{"VOID":3125},"10.1097\u002Fcad.0b013e3282f1da86",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-200802000-00010",[3129,3138,3160,3169,3189],{"id":3130,"sortIndex":115,"researcher":26,"roles":3131,"affiliations":3132,"properties":3133},"487d0246-9f60-443e-958c-1e1e33e6f09b",[],[],{"openalex":3134,"title":3136},{"VOID":3135},"A5053982213",{"EN":3137},"Maya Nair",{"id":3139,"sortIndex":111,"researcher":26,"roles":3140,"affiliations":3141,"properties":3153},"b8e3c121-fdb6-4d1f-b4fb-73eda3b5717a",[],[3142],{"id":3143,"sortIndex":36,"affiliation":3144,"properties":26},"bbb4ab82-b2a0-49b1-b058-ddb9d4931d02",{"id":3145,"createTime":3146,"updateTime":3147,"relativeEntities":3148,"slug":3149,"properties":3150,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5f8dd78b-efe0-4292-b73b-a787a07f10f3","2024-09-03T23:08:25.991+00:00","2025-02-09T10:34:14.613+00:00",[],"Univ-of-North-texas",{"title":3151},{"EN":3152},"Univ of North texas",{"openalex":3154,"orcid":3156,"title":3158},{"VOID":3155},"A5067970030",{"VOID":3157},"https:\u002F\u002Forcid.org\u002F0000-0001-9168-7802",{"EN":3159},"Andras G. Lacko",{"id":3161,"sortIndex":59,"researcher":26,"roles":3162,"affiliations":3163,"properties":3164},"bb42a560-b3f5-4dbe-ac95-9d775ae5b84a",[],[],{"openalex":3165,"title":3167},{"VOID":3166},"A5032573268",{"EN":3168},"Linda Mooberry",{"id":3170,"sortIndex":36,"researcher":26,"roles":3171,"affiliations":3172,"properties":3184},"f3ab14b9-a361-48a1-b7e4-d5538c1c80a9",[],[3173],{"id":3174,"sortIndex":36,"affiliation":3175,"properties":26},"7526c85a-d2dd-4006-b1bf-ccfe0ce7bc46",{"id":3176,"createTime":3177,"updateTime":3178,"relativeEntities":3179,"slug":3180,"properties":3181,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"02f035f4-d940-46be-921a-334407c3b371","2024-09-18T15:55:19.084+00:00","2025-06-11T16:18:41.986+00:00",[],"Department-of-Internal-Medicine-University-of-North-Texas-Health-Science-Center-Fort-Worth-Texas-76107-USA-",{"title":3182},{"EN":3183},"Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA.",{"openalex":3185,"title":3187},{"VOID":3186},"A5075398812",{"EN":3188},"Walter J. McConathy",{"id":3190,"sortIndex":114,"researcher":26,"roles":3191,"affiliations":3192,"properties":3193},"099b802a-c67a-42b2-bcea-4c1fd9266798",[],[],{"openalex":3194,"title":3196},{"VOID":3195},"A5024340258",{"EN":3197},"Sulabha Paranjape",{"url":26,"publisher":3199,"properties":3229},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3200,"slug":663,"properties":3201,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3207,"manageAffiliations":3208,"indexDatabases":3209,"url":803,"thumbnailPath":26,"statistic":3224,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3202,"issn":3203,"introduce":3204,"eissn":3205,"title":3206},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3210,3217],{"id":762,"indexDatabase":3211,"url":775,"indexYears":776,"academicFieldIds":3216,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":3212,"label":3213,"description":3214,"key":772,"publicationTags":3215,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":3218,"url":799,"indexYears":26,"academicFieldIds":3223,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":3219,"label":3220,"description":3221,"key":795,"publicationTags":3222,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":3225,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":3226,"totalCitation":807,"totalCitationByYear":3227,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":3228,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":3230,"pages":3232,"issue":3234},{"VOID":3231},"19",{"VOID":3233},"183-188",{"VOID":3235},"2",117,{"total":3236,"publishYear":26,"statisticByYear":3238},{"2012":53,"2013":103,"2014":50,"2015":356,"2016":158,"2017":135,"2018":162,"2019":50,"2020":158,"2021":50,"2022":114,"2023":111,"2024":59},"2008-02-01",2008,[3242,3246,3250,3254,3257,3260,3264,3268,3272,3276,3280,3284,3288,3292,3295,3299,3303,3307,3311,3314,3317,3321,3324,3328,3332,3336,3340,3344,3348],{"id":26,"text":3243,"url":26,"identifiers":3244},"Counsell, 1982, Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents, J Med Chem, 10, 1115, 10.1021\u002Fjm00352a001",{"doi":3245},"10.1021\u002Fjm00352a001",{"id":26,"text":3247,"url":26,"identifiers":3248},"Kader, 2002, Loading anticancer drugs into HDL as well as LDL has little effect on properties of complexes and enhances cytotoxicity to human carcinoma cells, J Control Release, 80, 29, 10.1016\u002FS0168-3659(01)00536-3",{"doi":3249},"10.1016\u002FS0168-3659(01)00536-3",{"id":26,"text":3251,"url":26,"identifiers":3252},"Firestone, 1984, Selective delivery of cytotoxic compounds to cells by the LDL pathway, J Med Chem, 27, 1037, 10.1021\u002Fjm00374a017",{"doi":3253},"10.1021\u002Fjm00374a017",{"id":26,"text":3255,"url":26,"identifiers":3256},"Lacko, 2002, High density lipoprotein complexes as delivery vehicles for anticancer drugs, Anticancer Res, 22, 2045",{},{"id":26,"text":3258,"url":26,"identifiers":3259},"Lacko, 2007, Nanotechnology in cancer therapy, 777",{},{"id":26,"text":3261,"url":26,"identifiers":3262},"Lacko, 2006, Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model, Chemotherapy, 52, 171, 10.1159\u002F000093268",{"doi":3263},"10.1159\u002F000093268",{"id":26,"text":3265,"url":26,"identifiers":3266},"Brewer, 1986, Isolation and characterization of apolipoprotein A-I, A-II and A-IV, Methods Enzymol, 128, 223, 10.1016\u002F0076-6879(86)28070-2",{"doi":3267},"10.1016\u002F0076-6879(86)28070-2",{"id":26,"text":3269,"url":26,"identifiers":3270},"Matz, 1982, Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersion, J Biol Chem, 257, 4535, 10.1016\u002FS0021-9258(18)34756-2",{"doi":3271},"10.1016\u002FS0021-9258(18)34756-2",{"id":26,"text":3273,"url":26,"identifiers":3274},"Jonas, 1986, Reconstitution of high density lipoproteins, Methods Enzymol, 128, 553, 10.1016\u002F0076-6879(86)28092-1",{"doi":3275},"10.1016\u002F0076-6879(86)28092-1",{"id":26,"text":3277,"url":26,"identifiers":3278},"Kelley, 1986, Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor, Methods Enzymol, 128, 170, 10.1016\u002F0076-6879(86)28067-2",{"doi":3279},"10.1016\u002F0076-6879(86)28067-2",{"id":26,"text":3281,"url":26,"identifiers":3282},"Terpstra, 1981, Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation, Anal Biochem, 111, 49, 10.1016\u002F0003-2697(81)90243-8",{"doi":3283},"10.1016\u002F0003-2697(81)90243-8",{"id":26,"text":3285,"url":26,"identifiers":3286},"Loney, 1997, Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis, Am J Ther, 9–10, 301, 10.1097\u002F00045391-199709000-00004",{"doi":3287},"10.1097\u002F00045391-199709000-00004",{"id":26,"text":3289,"url":26,"identifiers":3290},"Forte, 1971, Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy, J Clin Invest, 50, 1141, 10.1172\u002FJCI106586",{"doi":3291},"10.1172\u002FJCI106586",{"id":26,"text":3293,"url":26,"identifiers":3294},"Arnould, 1990, Comparison of two cytotoxicity assays – tetrazolium derivative reduction (MTT) and tritiated thymidine uptake – on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs, Anticancer Res, 10, 145",{},{"id":26,"text":3296,"url":26,"identifiers":3297},"Urrutia-Rojas, 2004, Cardiovascular risk factors in Mexican Americans at risk for type 2 diabetes mellitus, J Adolescent Health, 34, 290, 10.1016\u002Fj.jadohealth.2003.07.005",{"doi":3298},"10.1016\u002Fj.jadohealth.2003.07.005",{"id":26,"text":3300,"url":26,"identifiers":3301},"Kieft, 1991, Rapid online determination of cholesterol among plasma lipoproteins after high performance gel filtration chromatography, J Lipid Res, 32, 859, 10.1016\u002FS0022-2275(20)42037-1",{"doi":3302},"10.1016\u002FS0022-2275(20)42037-1",{"id":26,"text":3304,"url":26,"identifiers":3305},"Ackers, 1970, Analytical gel chromatography of proteins, Adv Protein Chem, 24, 343, 10.1016\u002FS0065-3233(08)60245-4",{"doi":3306},"10.1016\u002FS0065-3233(08)60245-4",{"id":26,"text":3308,"url":26,"identifiers":3309},"Gal, 1981, Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms, Am J Obstet Gynecol, 139, 877, 10.1016\u002F0002-9378(81)90952-2",{"doi":3310},"10.1016\u002F0002-9378(81)90952-2",{"id":26,"text":3312,"url":26,"identifiers":3313},"Peterson, 1991, Lipoproteins, malignancy, and anticancer agents, Targeted Diagn Ther, 5, 175",{},{"id":26,"text":3315,"url":26,"identifiers":3316},"Lundberg, 1987, Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway, Cancer Res, 47, 4105",{},{"id":26,"text":3318,"url":26,"identifiers":3319},"Cao, 2004, Mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells, Cancer Res, 64, 1515, 10.1158\u002F0008-5472.CAN-03-0675",{"doi":3320},"10.1158\u002F0008-5472.CAN-03-0675",{"id":26,"text":3322,"url":26,"identifiers":3323},"Markel, 2004, Cancer and hypocholesterolemia, Isr J Med Sci, 30, 787",{},{"id":26,"text":3325,"url":26,"identifiers":3326},"Vitols, 1990, Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy, Proc Natl Acad Sci U S A, 87, 2598, 10.1073\u002Fpnas.87.7.2598",{"doi":3327},"10.1073\u002Fpnas.87.7.2598",{"id":26,"text":3329,"url":26,"identifiers":3330},"Goncalves, 2005, Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells, Leuk Res, 29, 955, 10.1016\u002Fj.leukres.2005.01.013",{"doi":3331},"10.1016\u002Fj.leukres.2005.01.013",{"id":26,"text":3333,"url":26,"identifiers":3334},"Zheng, 2005, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents, Proc Natl Acad Sci U S A, 102, 17757, 10.1073\u002Fpnas.0508677102",{"doi":3335},"10.1073\u002Fpnas.0508677102",{"id":26,"text":3337,"url":26,"identifiers":3338},"Ryan, 2003, Optimized bacterial expression of human apolipoprotein A-I, Protein Expr Purif, 27, 98, 10.1016\u002FS1046-5928(02)00568-5",{"doi":3339},"10.1016\u002FS1046-5928(02)00568-5",{"id":26,"text":3341,"url":26,"identifiers":3342},"Baillie, 2002, A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro, J Lipid Res, 43, 69, 10.1016\u002FS0022-2275(20)30188-7",{"doi":3343},"10.1016\u002FS0022-2275(20)30188-7",{"id":26,"text":3345,"url":26,"identifiers":3346},"Owens, 2001, Physicochemical properties of microemulsion analogues of low density lipoprotein containing amphiphatic apoprotein B receptor sequences, Int J Pharm, 228, 109, 10.1016\u002FS0378-5173(01)00818-3",{"doi":3347},"10.1016\u002FS0378-5173(01)00818-3",{"id":26,"text":3349,"url":26,"identifiers":3350},"Nikanjam, 2007, Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme, Int J Pharm, 328, 86, 10.1016\u002Fj.ijpharm.2006.07.046",{"doi":3351},"10.1016\u002Fj.ijpharm.2006.07.046",{"id":3353,"createTime":3354,"updateTime":3354,"relativeEntities":3355,"slug":3356,"properties":3357,"entityType":835,"verifyStatus":25,"verifyTime":3354,"verifyNote":837,"syncStatus":28,"languages":3370,"translateLanguages":26,"viewCount":36,"primaryUrl":3371,"fullTextUrl":26,"authors":3372,"publicationType":922,"publisherRelationship":3394,"citationCount":3431,"citationInfo":3432,"publishDate":3434,"publishYear":3435,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3436,"isForceReanalyzing":1544},"46fb0057-fd9f-4bc4-9991-c7210c7f95e7","2024-09-27T20:04:09.338+00:00",[],"Use-of-corticosteroids-in-neuro-oncology",{"mag":3358,"keywords":3360,"openalex":3361,"abstract":3363,"title":3364,"pm":3366,"doi":3368},{"VOID":3359},"1993029481",{},{"VOID":3362},"W1993029481",{},{"EN":3365},"Use of corticosteroids in neuro-oncology",{"VOID":3367},"7756680",{"VOID":3369},"10.1097\u002F00001813-199502000-00002",[102],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199502000-00002",[3373],{"id":3374,"sortIndex":36,"researcher":26,"roles":3375,"affiliations":3376,"properties":3387},"bacc7c4b-4501-4178-be6c-47165a0df3f9",[],[3377],{"id":3378,"sortIndex":36,"affiliation":3379,"properties":26},"e87a8e85-af03-4cfc-bb3d-c631301b8eab",{"id":3380,"createTime":3381,"updateTime":3381,"relativeEntities":3382,"slug":3383,"properties":3384,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"985f5233-7cc2-40dd-bbb3-b17fdd6df5a3","2024-09-27T20:04:09.355+00:00",[],"Department-of-Neurology-de-Wever-Gregorius-Hospital-Heerlen-The-Netherlands-",{"title":3385},{"EN":3386},"Department of Neurology, de Wever & Gregorius Hospital, Heerlen, The Netherlands.",{"openalex":3388,"orcid":3390,"title":3392},{"VOID":3389},"A5028077073",{"VOID":3391},"https:\u002F\u002Forcid.org\u002F0000-0003-4356-2698",{"EN":3393},"Philip J. Koehler",{"url":26,"publisher":3395,"properties":3425},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3396,"slug":663,"properties":3397,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3403,"manageAffiliations":3404,"indexDatabases":3405,"url":803,"thumbnailPath":26,"statistic":3420,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3398,"issn":3399,"introduce":3400,"eissn":3401,"title":3402},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3406,3413],{"id":762,"indexDatabase":3407,"url":775,"indexYears":776,"academicFieldIds":3412,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":3408,"label":3409,"description":3410,"key":772,"publicationTags":3411,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":3414,"url":799,"indexYears":26,"academicFieldIds":3419,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":3415,"label":3416,"description":3417,"key":795,"publicationTags":3418,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":3421,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":3422,"totalCitation":807,"totalCitationByYear":3423,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":3424,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":3426,"pages":3428,"issue":3430},{"VOID":3427},"6",{"VOID":3429},"19-33",{"VOID":1788},116,{"total":3431,"publishYear":26,"statisticByYear":3433},{"2012":52,"2013":59,"2014":114,"2015":135,"2016":162,"2018":162,"2019":114,"2020":135,"2021":59,"2022":59,"2023":59,"2024":115},"1995-02-01",1995,[],{"id":3438,"createTime":3439,"updateTime":3439,"relativeEntities":3440,"slug":3441,"properties":3442,"entityType":835,"verifyStatus":28,"verifyTime":3439,"verifyNote":2247,"syncStatus":28,"languages":3455,"translateLanguages":26,"viewCount":36,"primaryUrl":3456,"fullTextUrl":26,"authors":3457,"publicationType":922,"publisherRelationship":3588,"citationCount":810,"citationInfo":3626,"publishDate":3628,"publishYear":3629,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3630,"isForceReanalyzing":1544},"495971bf-2c37-4b78-ba8b-f437043f56cc","2024-09-25T11:24:46.453+00:00",[],"Clinical-pharmacokinetics-of-doxorubicin-in-combination-with-GF120918-a-potent-inhibitor-of-MDR1-P-glycoprotein",{"mag":3443,"keywords":3445,"openalex":3446,"abstract":3448,"title":3449,"pm":3451,"doi":3453},{"VOID":3444},"2048424737",{},{"VOID":3447},"W2048424737",{},{"EN":3450},"Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein",{"VOID":3452},"10573204",{"VOID":3454},"10.1097\u002F00001813-199909000-00005",[102],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199909000-00005",[3458,3467,3478,3489,3500,3521,3530,3541,3550,3559,3570,3579],{"id":3459,"sortIndex":50,"researcher":26,"roles":3460,"affiliations":3461,"properties":3462},"c3bba118-9555-4a3a-8ced-4cd1f913d636",[],[],{"openalex":3463,"title":3465},{"VOID":3464},"A5057330708",{"EN":3466},"Linda Chandler",{"id":3468,"sortIndex":162,"researcher":26,"roles":3469,"affiliations":3470,"properties":3471},"525f5d50-39ef-4894-9805-51187d39dba3",[],[],{"openalex":3472,"orcid":3474,"title":3476},{"VOID":3473},"A5047240860",{"VOID":3475},"https:\u002F\u002Forcid.org\u002F0000-0003-3372-5756",{"EN":3477},"Peter de Bruijn",{"id":3479,"sortIndex":116,"researcher":26,"roles":3480,"affiliations":3481,"properties":3482},"e64903f3-9d29-4099-8965-bd82b430ceab",[],[],{"openalex":3483,"orcid":3485,"title":3487},{"VOID":3484},"A5069473904",{"VOID":3486},"https:\u002F\u002Forcid.org\u002F0000-0002-5790-8875",{"EN":3488},"Paul Wissel",{"id":3490,"sortIndex":52,"researcher":26,"roles":3491,"affiliations":3492,"properties":3493},"6f8d9380-7eea-482e-ac40-63594f2f9224",[],[],{"openalex":3494,"orcid":3496,"title":3498},{"VOID":3495},"A5027768129",{"VOID":3497},"https:\u002F\u002Forcid.org\u002F0000-0002-2975-2316",{"EN":3499},"Elaine Paul",{"id":3501,"sortIndex":36,"researcher":26,"roles":3502,"affiliations":3503,"properties":3514},"8891fe25-7539-4088-a908-82160fcf0346",[],[3504],{"id":3505,"sortIndex":36,"affiliation":3506,"properties":26},"34960c9f-52d8-4ab0-afce-8aac92da6013",{"id":3507,"createTime":3508,"updateTime":3508,"relativeEntities":3509,"slug":3510,"properties":3511,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"623a437b-726f-40f9-87ef-e7e0e7071737","2024-09-25T11:24:46.477+00:00",[],"Department-of-Medical-Oncology-Rotterdam-Cancer-Institute-Daniel-den-Hoed-Kliniek-and-University-Hospital-Rotterdam-The-Netherlands-sparreboom-onch-azr-nl",{"title":3512},{"EN":3513},"Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, The Netherlands. sparreboom@onch.azr.nl",{"openalex":3515,"orcid":3517,"title":3519},{"VOID":3516},"A5065279964",{"VOID":3518},"https:\u002F\u002Forcid.org\u002F0000-0003-2660-6644",{"EN":3520},"Alex Sparreboom",{"id":3522,"sortIndex":59,"researcher":26,"roles":3523,"affiliations":3524,"properties":3525},"4875cd80-6b78-4f4a-9bcf-16016a56dc5e",[],[],{"openalex":3526,"title":3528},{"VOID":3527},"A5103479396",{"EN":3529},"M E van der Burg",{"id":3531,"sortIndex":158,"researcher":26,"roles":3532,"affiliations":3533,"properties":3534},"0404f0c6-37ac-4b6e-b20e-ee52b5858bd7",[],[],{"openalex":3535,"orcid":3537,"title":3539},{"VOID":3536},"A5013888438",{"VOID":3538},"https:\u002F\u002Forcid.org\u002F0000-0002-0673-7236",{"EN":3540},"Erik A.C. Wiemer",{"id":3542,"sortIndex":114,"researcher":26,"roles":3543,"affiliations":3544,"properties":3545},"bbaef0b1-3447-4eaf-b37a-207ab5013f6f",[],[],{"openalex":3546,"title":3548},{"VOID":3547},"A5023508449",{"EN":3549},"Roxanne C. Jewell",{"id":3551,"sortIndex":135,"researcher":26,"roles":3552,"affiliations":3553,"properties":3554},"8a989db4-94d2-4199-ae64-bb612b61442d",[],[],{"openalex":3555,"title":3557},{"VOID":3556},"A5071869322",{"EN":3558},"W J Loos",{"id":3560,"sortIndex":111,"researcher":26,"roles":3561,"affiliations":3562,"properties":3563},"3a3d44c7-aebc-4393-abe9-a5fd91e804d4",[],[],{"openalex":3564,"orcid":3566,"title":3568},{"VOID":3565},"A5010810138",{"VOID":3567},"https:\u002F\u002Forcid.org\u002F0000-0003-1866-7367",{"EN":3569},"Ate van der Gaast",{"id":3571,"sortIndex":53,"researcher":26,"roles":3572,"affiliations":3573,"properties":3574},"08a8f7a7-d2ff-4ba3-bd93-a8844e968cef",[],[],{"openalex":3575,"title":3577},{"VOID":3576},"A5011819733",{"EN":3578},"Jaap Verweij",{"id":3580,"sortIndex":115,"researcher":26,"roles":3581,"affiliations":3582,"properties":3583},"9d6fad66-e61c-40dc-96f8-f7d01108b267",[],[],{"openalex":3584,"title":3586},{"VOID":3585},"A5005190279",{"EN":3587},"A. S. T. Planting",{"url":26,"publisher":3589,"properties":3619},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3590,"slug":663,"properties":3591,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3597,"manageAffiliations":3598,"indexDatabases":3599,"url":803,"thumbnailPath":26,"statistic":3614,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3592,"issn":3593,"introduce":3594,"eissn":3595,"title":3596},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3600,3607],{"id":762,"indexDatabase":3601,"url":775,"indexYears":776,"academicFieldIds":3606,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":3602,"label":3603,"description":3604,"key":772,"publicationTags":3605,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":3608,"url":799,"indexYears":26,"academicFieldIds":3613,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":3609,"label":3610,"description":3611,"key":795,"publicationTags":3612,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":3615,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":3616,"totalCitation":807,"totalCitationByYear":3617,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":3618,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":3620,"pages":3622,"issue":3624},{"VOID":3621},"10",{"VOID":3623},"719-728",{"VOID":3625},"8",{"total":810,"publishYear":26,"statisticByYear":3627},{"2012":162,"2013":114,"2014":115,"2016":59,"2017":111,"2018":114,"2019":111,"2020":114,"2021":114,"2022":114,"2024":115},"1999-09-01",1999,[],{"id":3632,"createTime":3633,"updateTime":3633,"relativeEntities":3634,"slug":3635,"properties":3636,"entityType":835,"verifyStatus":28,"verifyTime":3649,"verifyNote":2247,"syncStatus":28,"languages":3650,"translateLanguages":26,"viewCount":36,"primaryUrl":3651,"fullTextUrl":26,"authors":3652,"publicationType":922,"publisherRelationship":3757,"citationCount":810,"citationInfo":3795,"publishDate":3797,"publishYear":3798,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3799,"isForceReanalyzing":1544},"54bf980d-e22b-4d9c-9a69-309393964f1d","2024-09-02T03:01:55.194+00:00",[],"Betulinic-acid-delivered-in-liposomes-reduces-growth-of-human-lung-and-colon-cancers-in-mice-without-causing-systemic-toxicity",{"mag":3637,"keywords":3639,"openalex":3640,"abstract":3642,"title":3643,"pm":3645,"doi":3647},{"VOID":3638},"2031839901",{},{"VOID":3641},"W2031839901",{},{"EN":3644},"Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicity",{"VOID":3646},"21263311",{"VOID":3648},"10.1097\u002Fcad.0b013e3283421035","2024-09-02T03:01:55.193+00:00",[102],"https:\u002F\u002Fjournals.lww.com\u002F00001813-201103000-00004",[3653,3662,3673,3682,3693,3728,3739,3748],{"id":3654,"sortIndex":36,"researcher":26,"roles":3655,"affiliations":3656,"properties":3657},"2de3704b-847b-46a0-b5cc-c22b06252b38",[],[],{"openalex":3658,"title":3660},{"VOID":3659},"A5072262068",{"EN":3661},"Franziska B. Mullauer",{"id":3663,"sortIndex":162,"researcher":26,"roles":3664,"affiliations":3665,"properties":3666},"63703975-6196-4a73-85f7-80d0553c5e23",[],[],{"openalex":3667,"orcid":3669,"title":3671},{"VOID":3668},"A5035211563",{"VOID":3670},"https:\u002F\u002Forcid.org\u002F0000-0003-3045-2924",{"EN":3672},"Jan Paul Medema",{"id":3674,"sortIndex":115,"researcher":26,"roles":3675,"affiliations":3676,"properties":3677},"5058a661-e580-46fc-8b51-4c221c0f412a",[],[],{"openalex":3678,"title":3680},{"VOID":3679},"A5024138110",{"EN":3681},"Louis van Bloois",{"id":3683,"sortIndex":135,"researcher":26,"roles":3684,"affiliations":3685,"properties":3686},"13e536af-6656-416c-8a41-887cd74ae1bc",[],[],{"openalex":3687,"orcid":3689,"title":3691},{"VOID":3688},"A5025142700",{"VOID":3690},"https:\u002F\u002Forcid.org\u002F0000-0002-1012-9815",{"EN":3692},"Raymond M. Schiffelers",{"id":3694,"sortIndex":158,"researcher":26,"roles":3695,"affiliations":3696,"properties":3723},"50c5f2a2-4bab-4d89-854f-1e46bdd8da3f",[],[3697,3707,3717],{"id":3698,"sortIndex":114,"affiliation":3699,"properties":26},"e04582bf-7b49-41f5-ba82-2320742a3483",{"id":3700,"createTime":3701,"updateTime":3701,"relativeEntities":3702,"slug":3703,"properties":3704,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"795e65a7-08e6-442d-a68c-49e85f5e5c93","2024-09-02T03:01:55.242+00:00",[],"to-Jan-H-Kessler-PhD-Laboratory-for-Experimental-Oncology-and-Radiobiology-LEXOR-Center-for-Experimental-and-Molecular-Medicine-Academic-Medical-Center-AMC-Meibergdreef-9-Amsterdam-1105-AZ-The-Netherlands-Tel-31-71-526-3845",{"title":3705},{"EN":3706},"to Jan H. Kessler, PhD, Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine, Academic Medical Center (AMC), Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands Tel: +31 71 526 3845",{"id":3708,"sortIndex":115,"affiliation":3709,"properties":26},"a8448cbc-5109-4ba3-bdff-9ef43be40b6b",{"id":3710,"createTime":3711,"updateTime":3711,"relativeEntities":3712,"slug":3713,"properties":3714,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"68320755-b7dd-4d58-b520-68c8634a9fb0","2024-09-02T03:01:55.236+00:00",[],"fax-31-20-6977192",{"title":3715},{"EN":3716},"fax: +31 20 6977192",{"id":3718,"sortIndex":36,"affiliation":3719,"properties":26},"4ab6fd14-bb73-4f4a-bbf1-401d35ac3446",{"id":1653,"createTime":1654,"updateTime":1655,"relativeEntities":3720,"slug":1657,"properties":3721,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3722},{"EN":1660},{"openalex":3724,"title":3726},{"VOID":3725},"A5024140962",{"EN":3727},"Jan H. Kessler",{"id":3729,"sortIndex":111,"researcher":26,"roles":3730,"affiliations":3731,"properties":3732},"d8435259-b91f-47b3-b92c-9912836bb2d4",[],[],{"openalex":3733,"orcid":3735,"title":3737},{"VOID":3734},"A5023784321",{"VOID":3736},"https:\u002F\u002Forcid.org\u002F0000-0003-4296-2761",{"EN":3738},"Gert Storm",{"id":3740,"sortIndex":114,"researcher":26,"roles":3741,"affiliations":3742,"properties":3743},"5948d159-f091-4129-99a1-57d17a705c9f",[],[],{"openalex":3744,"title":3746},{"VOID":3745},"A5050478943",{"EN":3747},"Joost Daalhuisen",{"id":3749,"sortIndex":59,"researcher":26,"roles":3750,"affiliations":3751,"properties":3752},"fb8644dd-0a68-4938-9797-3f017c6bf7be",[],[],{"openalex":3753,"title":3755},{"VOID":3754},"A5042836312",{"EN":3756},"Marieke S. ten Brink",{"url":26,"publisher":3758,"properties":3788},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3759,"slug":663,"properties":3760,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3766,"manageAffiliations":3767,"indexDatabases":3768,"url":803,"thumbnailPath":26,"statistic":3783,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3761,"issn":3762,"introduce":3763,"eissn":3764,"title":3765},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3769,3776],{"id":762,"indexDatabase":3770,"url":775,"indexYears":776,"academicFieldIds":3775,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":3771,"label":3772,"description":3773,"key":772,"publicationTags":3774,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":3777,"url":799,"indexYears":26,"academicFieldIds":3782,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":3778,"label":3779,"description":3780,"key":795,"publicationTags":3781,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":3784,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":3785,"totalCitation":807,"totalCitationByYear":3786,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":3787,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":3789,"pages":3791,"issue":3793},{"VOID":3790},"22",{"VOID":3792},"223-233",{"VOID":3794},"3",{"total":810,"publishYear":26,"statisticByYear":3796},{"2012":135,"2013":59,"2014":158,"2015":59,"2016":111,"2017":116,"2018":50,"2019":135,"2020":53,"2021":356,"2022":111,"2023":50,"2024":158},"2011-03-01",2011,[3800],{"id":26,"text":3801,"url":26,"identifiers":3802},"Sandberg, 1987, Spondianthus preussii var. grabber Engler., Pharmacological screening and occurrence of triterpenes Acta Pharm Suec, 24, 253",{},{"id":3804,"createTime":3805,"updateTime":3805,"relativeEntities":3806,"slug":3807,"properties":3808,"entityType":835,"verifyStatus":25,"verifyTime":3805,"verifyNote":837,"syncStatus":28,"languages":3821,"translateLanguages":26,"viewCount":36,"primaryUrl":3822,"fullTextUrl":26,"authors":3823,"publicationType":922,"publisherRelationship":3894,"citationCount":3931,"citationInfo":3932,"publishDate":3934,"publishYear":3935,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3936,"isForceReanalyzing":1544},"bfd3c6aa-c1a9-43d8-a571-75b045085169","2025-01-30T01:44:29.935+00:00",[],"Structure-activity-studies-on-gossypol-in-tumor-cell-lines",{"mag":3809,"keywords":3811,"openalex":3812,"abstract":3814,"title":3815,"pm":3817,"doi":3819},{"VOID":3810},"2334754091",{},{"VOID":3813},"W2334754091",{},{"EN":3816},"Structure-activity studies on gossypol in tumor cell lines",{"VOID":3818},"10831280",{"VOID":3820},"10.1097\u002F00001813-200003000-00009",[102],"http:\u002F\u002Fjournals.lww.com\u002F00001813-200003000-00009",[3824,3843,3858,3873],{"id":3825,"sortIndex":59,"researcher":26,"roles":3826,"affiliations":3827,"properties":3838},"18c8a3a9-0d98-4cea-8928-fcf1714d6389",[],[3828],{"id":3829,"sortIndex":36,"affiliation":3830,"properties":26},"dc45ea44-0e87-482b-9077-6d224fb03a9c",{"id":3831,"createTime":3832,"updateTime":3832,"relativeEntities":3833,"slug":3834,"properties":3835,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6b9f7ec6-0b70-4fd2-87b8-953beca4eee3","2025-01-30T01:44:30.001+00:00",[],"Research-Laboratories-Velindre-NHS-Trust-Whitchurch-Cardiff-CF14-2TL-UK-",{"title":3836},{"EN":3837},"Research Laboratories, Velindre NHS Trust, Whitchurch, Cardiff, CF14 2TL, UK.",{"openalex":3839,"title":3841},{"VOID":3840},"A5113537286",{"EN":3842},"Reginald G. Fish",{"id":3844,"sortIndex":115,"researcher":26,"roles":3845,"affiliations":3846,"properties":3853},"8c41b775-17fc-4968-b9da-fb0a49c1b127",[],[3847],{"id":3848,"sortIndex":36,"affiliation":3849,"properties":26},"94bc2656-2c44-4063-b8dd-73633bd17d88",{"id":3831,"createTime":3832,"updateTime":3832,"relativeEntities":3850,"slug":3834,"properties":3851,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3852},{"EN":3837},{"openalex":3854,"title":3856},{"VOID":3855},"A5047684688",{"EN":3857},"Laura Hartley",{"id":3859,"sortIndex":36,"researcher":26,"roles":3860,"affiliations":3861,"properties":3868},"6993e389-867e-424e-8792-26fa31a0c98a",[],[3862],{"id":3863,"sortIndex":36,"affiliation":3864,"properties":26},"aa9e6e2b-16bf-498c-a00a-6fe631fff95a",{"id":3831,"createTime":3832,"updateTime":3832,"relativeEntities":3865,"slug":3834,"properties":3866,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3867},{"EN":3837},{"openalex":3869,"title":3871},{"VOID":3870},"A5105457216",{"EN":3872},"M. Shelley",{"id":3874,"sortIndex":114,"researcher":26,"roles":3875,"affiliations":3876,"properties":3887},"ea706972-d0b5-4602-b9a5-e03eb8dd4cf0",[],[3877],{"id":3878,"sortIndex":36,"affiliation":3879,"properties":26},"5cff1a78-828c-4913-8480-a924840f3a8a",{"id":3880,"createTime":3881,"updateTime":3881,"relativeEntities":3882,"slug":3883,"properties":3884,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5fa76bd8-6d34-4e27-a04c-5c0d947ac2b1","2025-01-30T01:44:30.128+00:00",[],"School-of-Health-Sciences-University-of-Sunderland-Sunderland-SR2-3SD-UK-",{"title":3885},{"EN":3886},"School of Health Sciences, University of Sunderland, Sunderland, SR2 3SD, UK.",{"openalex":3888,"orcid":3890,"title":3892},{"VOID":3889},"A5067632543",{"VOID":3891},"https:\u002F\u002Forcid.org\u002F0000-0002-4932-2030",{"EN":3893},"Paul W. Groundwater",{"url":26,"publisher":3895,"properties":3925},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3896,"slug":663,"properties":3897,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3903,"manageAffiliations":3904,"indexDatabases":3905,"url":803,"thumbnailPath":26,"statistic":3920,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3898,"issn":3899,"introduce":3900,"eissn":3901,"title":3902},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3906,3913],{"id":762,"indexDatabase":3907,"url":775,"indexYears":776,"academicFieldIds":3912,"indexDatabaseRanking":782},{"id":764,"createTime":765,"updateTime":766,"relativeEntities":3908,"label":3909,"description":3910,"key":772,"publicationTags":3911,"standard":26},[],{"EN":769,"VI":769},{"EN":769,"VI":771},[774],[778,779,780,781],{"id":784,"indexDatabase":3914,"url":799,"indexYears":26,"academicFieldIds":3919,"indexDatabaseRanking":26},{"id":786,"createTime":787,"updateTime":788,"relativeEntities":3915,"label":3916,"description":3917,"key":795,"publicationTags":3918,"standard":26},[],{"EN":791,"VI":791},{"VI":793,"EN":794},[797,798],[801,802],{"impactFactor":36,"impactFactorByYear":3921,"i10Index":135,"i10IndexLast5Year":36,"totalPublication":135,"totalPublicationByYear":3922,"totalCitation":807,"totalCitationByYear":3923,"totalCitationPerPublication":811,"totalCitationPerPublicationByYear":3924,"hindexLast5Year":135,"hindex":135},{"2012":135,"2013":114,"2014":114,"2016":111,"2017":114},{"1995":115,"2004":115,"2007":115,"2011":115,"2012":115,"2015":115},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"1995":809,"2004":569,"2007":255,"2011":810,"2012":284,"2015":239},{"volume":3926,"pages":3928,"issue":3930},{"VOID":3927},"11",{"VOID":3929},"209-216",{"VOID":3794},90,{"total":3931,"publishYear":26,"statisticByYear":3933},{"2012":114,"2013":111,"2014":114,"2015":162,"2016":111,"2017":59,"2018":111,"2019":135,"2020":111,"2021":162,"2023":162,"2024":114},"2000-03-01",2000,[3937,3941,3945,3949,3953,3956,3959,3962,3966,3970,3974,3977,3981,3985,3989,3993,3997,4001,4004,4008,4011,4015,4018,4022,4026,4029,4033],{"id":26,"text":3938,"url":26,"identifiers":3939},"Qian, 1984, Annu Rev Pharmacol Toxicol, 24, 329, 10.1146\u002Fannurev.pa.24.040184.001553",{"doi":3940},"10.1146\u002Fannurev.pa.24.040184.001553",{"id":26,"text":3942,"url":26,"identifiers":3943},"Radloff, 1986, Pharmacol Res Commun, 18, 1063, 10.1016\u002F0031-6989(86)90023-8",{"doi":3944},"10.1016\u002F0031-6989(86)90023-8",{"id":26,"text":3946,"url":26,"identifiers":3947},"Montamat, 1982, Science, 218, 288, 10.1126\u002Fscience.6750791",{"doi":3948},"10.1126\u002Fscience.6750791",{"id":26,"text":3950,"url":26,"identifiers":3951},"Benhaim, 1994, Inflammation, 18, 443, 10.1007\u002FBF01560692",{"doi":3952},"10.1007\u002FBF01560692",{"id":26,"text":3954,"url":26,"identifiers":3955},"Tuszynski, 1984, Cancer Res, 44, 768",{},{"id":26,"text":3957,"url":26,"identifiers":3958},"Wu, 1989, Cancer Res, 49, 3753",{},{"id":26,"text":3960,"url":26,"identifiers":3961},"Jaroszewski, 1990, Cancer Res, 50, 6936",{},{"id":26,"text":3963,"url":26,"identifiers":3964},"Coyle, 1994, J Neuro-Oncol, 19, 25, 10.1007\u002FBF01051046",{"doi":3965},"10.1007\u002FBF01051046",{"id":26,"text":3967,"url":26,"identifiers":3968},"Benz, 1987, J Clin Invest, 79, 517, 10.1172\u002FJCI112842",{"doi":3969},"10.1172\u002FJCI112842",{"id":26,"text":3971,"url":26,"identifiers":3972},"Rao, 1985, Cancer Chemother Pharmacol, 15, 20, 10.1007\u002FBF00257288",{"doi":3973},"10.1007\u002FBF00257288",{"id":26,"text":3975,"url":26,"identifiers":3976},"Chang, 1993, Res Commun Chem Pathol Pharmacol, 79, 293",{},{"id":26,"text":3978,"url":26,"identifiers":3979},"Flack, 1993, J Clin Endocrinol Metab, 76, 1019, 10.1210\u002Fjc.76.4.1019",{"doi":3980},"10.1210\u002Fjc.76.4.1019",{"id":26,"text":3982,"url":26,"identifiers":3983},"Tanphaichitr, 1995, Chem Physics Lipids, 75, 119, 10.1016\u002F0009-3084(94)02412-X",{"doi":3984},"10.1016\u002F0009-3084(94)02412-X",{"id":26,"text":3986,"url":26,"identifiers":3987},"Laughton, 1989, Biochem Pharmacol, 38, 2859, 10.1016\u002F0006-2952(89)90442-5",{"doi":3988},"10.1016\u002F0006-2952(89)90442-5",{"id":26,"text":3990,"url":26,"identifiers":3991},"Cater, 1969, J Am Oil Chem Soc, 64, 649, 10.1007\u002FBF02540621",{"doi":3992},"10.1007\u002FBF02540621",{"id":26,"text":3994,"url":26,"identifiers":3995},"Fish, 1995, Tetrahedron: Asymmetry, 6, 873, 10.1016\u002F0957-4166(95)00093-5",{"doi":3996},"10.1016\u002F0957-4166(95)00093-5",{"id":26,"text":3998,"url":26,"identifiers":3999},"Medrano, 1986, Eur J Biochem, 158, 63, 10.1111\u002Fj.1432-1033.1986.tb09721.x",{"doi":4000},"10.1111\u002Fj.1432-1033.1986.tb09721.x",{"id":26,"text":4002,"url":26,"identifiers":4003},"Appu Rao, 1992, Indian J Biochem Biophys, 29, 179",{},{"id":26,"text":4005,"url":26,"identifiers":4006},"Levinsky, 1991, Andrologia, 23, 159, 10.1111\u002Fj.1439-0272.1991.tb02522.x",{"doi":4007},"10.1111\u002Fj.1439-0272.1991.tb02522.x",{"id":26,"text":4009,"url":26,"identifiers":4010},"Rekha, 1996, New York: Plenum Press, 133-, 45",{},{"id":26,"text":4012,"url":26,"identifiers":4013},"Clark, 1928, J Biol Chem, 78, 159, 10.1016\u002FS0021-9258(18)84027-3",{"doi":4014},"10.1016\u002FS0021-9258(18)84027-3",{"id":26,"text":4016,"url":26,"identifiers":4017},"Lin, 1993, Biochem Pharmacol, 46, 251",{},{"id":26,"text":4019,"url":26,"identifiers":4020},"Abou-Donia, 1975, Toxicol Appl Pharmacol, 31, 32, 10.1016\u002F0041-008X(75)90049-6",{"doi":4021},"10.1016\u002F0041-008X(75)90049-6",{"id":26,"text":4023,"url":26,"identifiers":4024},"Brezezinski, 1990, J Mol Structure, 220, 261, 10.1016\u002F0022-2860(90)80116-2",{"doi":4025},"10.1016\u002F0022-2860(90)80116-2",{"id":26,"text":4027,"url":26,"identifiers":4028},"Ross, 1989, Cancer Res, 49, 3776",{},{"id":26,"text":4030,"url":26,"identifiers":4031},"Hoffer, 1988, Contraception, 37, 301, 10.1016\u002F0010-7824(88)90032-7",{"doi":4032},"10.1016\u002F0010-7824(88)90032-7",{"id":26,"text":4034,"url":26,"identifiers":4035},"Liang, 1995, Invest New Drugs, 13, 181, 10.1007\u002FBF00873798",{"doi":4036},"10.1007\u002FBF00873798"]